Abstract
Ferroptosis is an emerging form of programmed cell death triggered by iron-dependent lipid peroxidation. It is distinguished from other forms of cell death by its unique morphological changes and characteristic fine-tuned regulatory gene network. Since its pivotal involvement in the pathogenesis and therapeutic interventions of various diseases, such as malignant tumors, cardiovascular and cerebrovascular diseases, and traumatic disorders, has been well-established, ferroptosis has garnered significant attention in contemporary physiological and pathological research. For the advantage of alleviating the clinical symptoms and improving life quality, traditional Chinese medicine (TCM) holds a significant position in the treatment of these ailments. Moreover, increasing studies revealed that TCM compounds and monomers showed evident therapeutic efficacy by regulating ferroptosis via signaling pathways that tightly regulate redox reactions, iron ion homeostasis, lipid peroxidation, and glutathione metabolism. In this paper, we summarized the current knowledge of TCM compounds and monomers in regulating ferroptosis, aiming to provide a comprehensive review of disease management by TCM decoction, Chinese patent medicine, and natural products deriving from TCM through ferroptosis modulation. The formulation composition, chemical structure, and possible targets or mechanisms presented here offer valuable insights into the advancement of TCM exploration.
Keywords: Chemical construction, Compounds, Ferroptosis, Monomers, Traditional Chinese medicine
Introduction
In 2012, Dixon et al1 proposed the concept of ferroptosis. Ferroptosis is a complex process involving the antioxidant system (SLC7A11, GPX4, FSP1, NADPH, etc.), iron metabolism (TFRC, STEAP3, FTH, FTL1, etc.), and lipid metabolism (ACSL4, LPCAT3, ALOXs, etc.).2 The regulation of the above key molecules potentially influences the occurrence of ferroptosis. Ferroptosis is a type of cell death that is dependent on reactive oxygen species (ROS) and is characterized by the accumulation of iron and lipid peroxidation. This process is closely linked to the reductive/oxidative (redox) metabolic processes that occur within cells.
The ferroptosis process has been implicated in many diseases, such as cardiovascular disease, ischemia-reperfusion injury, neurodegenerative disease, and cancer.3, 4, 5, 6 Traditional Chinese medicine (TCM) has been used extensively in the clinic to treat the above diseases and demonstrates evident therapeutic efficacy. In recent years, there has been a proliferation of studies highlighting the therapeutic abilities of TCM, encompassing both compounds and monomers, to modulate ferroptosis and thereby achieve disease treatment. TCM possesses distinct advantages in regulating redox-dependent metabolic processes, as evidenced by multiple studies demonstrating its efficacy in mitigating disorders through the modulation of ferroptosis.7 The therapeutic foundation of TCM is based on its active pharmaceutical constituents, which can be categorized based on their chemical composition. These include glycosides, quinoids, flavonoids, terpenoids, organic acids, alkaloids, and other compounds. It is expected that the integration of TCM, natural medicinal chemistry technology, and contemporary pharmacological experimental methods will facilitate the investigation of the correlation between the structure and activity of the active ingredients. Additionally, this approach will enable the identification of key compounds and facilitate structural modification and transformation. Ultimately, this research will serve as a foundation for the development of novel medications characterized by enhanced efficacy, improved target selectivity, reduced toxicity and side effects, and enhanced safety.
Characteristics of ferroptosis
Ferroptosis is a novel form of programmed cell death characterized by iron-dependent lipid peroxidation. This type of death is distinct from traditional forms such as apoptosis and necrosis. Morphologically, cells undergoing ferroptosis exhibit necrosis-like changes, including loss of membrane integrity, cytoplasmic swelling, intracellular organelle swelling, and moderate chromatin condensation.2 Ferroptosis causes ultrastructural abnormalities in mitochondria, including reduced or absent cristae, rupture of the outer membrane, or increased membrane density2 (Fig. 1A).
Figure 1.
Characteristics of ferroptosis. (A) Morphological and biochemical characteristics of ferroptosis. (B) Core regulatory proteins of ferroptosis.
The process of ferroptosis has distinct biochemical characteristics, such as excessive ROS, iron accumulation, and lipid peroxidation (Fig. 1A). During ferroptosis, there is either overexpression or low expression of key proteins. The abnormal expression of these proteins is closely related to the biochemical characteristics of ferroptosis (Fig. 1B). Excessive ROS is mainly caused by an imbalance in the redox state. The proteins regulating redox state in cells are primarily anti-oxidant system proteins, including GPX4 (glutathione peroxidase 4), NRF2 (nuclear factor erythroid 2-related factor 2), SLC7A11 (solute carrier family 7 member 11), and NADPH (nicotinamide adenine dinucleotide phosphate).8 The proteins related to iron accumulation include TFRC (transferrin receptor), STEAP3 (six-transmembrane epithelial antigen of prostate 3), FTH (ferritin heavy chain), and FTL1 (ferritin light chain 1).2 In ferroptosis, specific membrane lipid peroxidation plays a decisive role in cell death, with ACSL4 (acyl-CoA synthetase long-chain family member 4) and LPCAT3 (lysophosphatidylcholine acyltransferase 3) playing key roles in this process.9 The proteins mentioned above are crucial in ferroptosis and become key targets for its regulation.
TCM compounds regulating ferroptosis
Malignant tumors, cardiovascular diseases, cerebrovascular diseases, and traumatic diseases are significant maladies that pose a threat to human health. Ferroptosis plays a pivotal role in the pathogenesis and progression of these diseases. TCM compounds have greatly contributed to the therapeutic management of these diseases. Consequently, the classification of disorders is one method that can be used to assess the relationship between the control of ferroptosis and these compounds.
Malignant tumors
Fuzheng Kang’ai Decoction, a formulation comprising 12 Chinese herbal medicines, namely, Radix Pseudostellariae, Rhizoma Atractylodis macrocephalae, Milkvetch Root, Hedyotis Diffusa, Solanum Nigrum, Chinese Sage Herb, Indian Iphigenia Bulb, Coix Seed, Akebia Trifoliata Koidz, Snake Bubble Ilicifolius, Curcuma Zedoaria, and Licorice, has been extensively utilized in China for several decades as a treatment for patients with non-small cell lung cancer (NSCLC), and it exhibits unequivocal therapeutic outcomes in clinical settings.10, 11, 12 Zhao et al13 discovered that Fuzheng Kang’ai Decoction effectively triggered ferroptosis in NSCLC cells through the augmentation of lipid peroxidation and the abundance of intracellular Fe2+ ions. Subsequent investigations have substantiated the pivotal involvement of GPX4 in the induction of Fuzheng Kang’ai Decoction-mediated ferroptosis in NSCLC cells.13
Qingre Huoxue Formula, comprising Scutellaria baicalensis and Radix paeoniae rubra, is frequently used in the treatment of chronic obstructive pulmonary disease and lung cancer.14 Xu et al14 discovered that Qingre Huoxue Formula exhibits the ability to stimulate ferroptosis and apoptosis, thereby inhibiting the growth of NSCLC cells through the involvement of the p53 and GSK-3β (glycogen synthase kinase 3 beta)/Nrf2 signaling pathways.
Fuzheng Nizeng Decoction, a derivative of the renowned Liujunzi Decoction, has demonstrated favorable clinical efficacy in the treatment of gastric precancerous lesions according to clinical studies.15 Chu et al16 discovered that Fuzheng Nizeng Decoction can induce ferroptosis and endoplasmic reticulum stress in MNNG (N-methyl-N′’-nitro-N-nitrosoguanidine)-induced gastric precancerous lesion cells, leading to a reduction in GPX4/glutathione (GSH) levels. Furthermore, it was observed that the ATF3 (activating transcription factor 3)/CHOP (CCAAT-enhancer-binding protein homologous protein)/CHAC1 (ChaC glutathione specific gamma-glutamylcyclotransferase 1) signaling pathway may engage in crosstalk, thereby offering a novel molecular mechanism for the management of gastric precancerous lesions.16
The formulation of Shuganning Injection is derived from the traditional prescription Yinchenhao Decoction, which was originally documented in the Treatise on Cold Damage Diseases compiled by Zhongjing Zhang approximately 1800 years ago. Shuganning Injection received approval as a traditional Chinese patent medicine from the China Food and Drug Administration in 2002, as stated in the Pharmacopoeia of 2005. Due to its hepatoprotective and immunomodulatory properties, Shuganning Injection is extensively utilized as an adjuvant therapy for cancer, particularly in cases of hepatic carcinomas.17,18 Du et al19 discovered that the induction of ferroptosis by Shuganning Injection was contingent upon the presence of HO-1 (heme oxygenase 1), which facilitated the accumulation of labile iron pools within the cell. This effect was mitigated through the knockdown of HO-1 and the inhibition of its activity using tin protoporphyrin IX.19
Cardiovascular and cerebrovascular diseases
The composition of DiDang Decoction (DDD) includes rhubarb, peach seed, leech, and gadfly. It is known for its ability to alleviate stagnancy and eliminate blood stasis, as originally documented in the Treatise on Febrile Diseases and Synopsis of Prescriptions of the Golden Chamber. Over several years, it has been extensively utilized in clinical practice for the treatment of various metabolic disorders. Furthermore, numerous randomized control trials have demonstrated the significant efficacy of DiDang Decoction in managing atherosclerosis and hyperlipidemia.20,21 Wu et al22 provided evidence that DDD exhibited therapeutic effects on atherosclerosis and hyperlipidemia by targeting multiple pathways and mechanisms, leading to improvements in mitochondrial function, reduction in ROS levels, and inhibition of ferroptosis and apoptosis, which were achieved through the activation of the HIF-1 (hypoxia-inducible factor 1) signaling pathway.
Academician Chen Keji’s representative prescription, Qingxin Jieyu Granule, is formulated based on the etiology and pathogenesis of “blood stasis pattern” and is commonly used for the treatment of atherosclerotic cardiovascular diseases.23 A network pharmacology study conducted by Zhang et al revealed that the regulation of macrophage ferroptosis serves as a crucial pathway through which Qingxin Jieyu Granule effectively stabilizes vulnerable atherosclerosis plaques. The study further demonstrated that Qingxin Jieyu Granule exerts its inhibitory effects on ferroptosis in vulnerable atherosclerosis plaques, partially mediated by the GPX4/xCT (the cystine/glutamate antiporter SLC7A11) signaling pathway.24
Foshousan, a traditional Chinese herbal decoction, was first documented in Puji Benshi Fang during the Song Dynasty (AD 1132) by Shuwei Xu. It consists of Angelica sinensis and Ligusticum wallichii in a weight ratio of 3:2.25 In recent years, it has been extensively utilized in the treatment of diverse ailments, with a particular focus on cerebral vascular impairment.26,27 Wang et al25 conducted a study demonstrating the potential of Foshousan to mitigate cognitive deficits induced by chronic cerebral hypoperfusion through modulation of the NRF2/HO-1 pathway against ferroptosis. Additionally, Compound Tongluo Decoction, a TCM formulation, exhibits a range of pharmacological abilities, such as hepatic and renal nourishment, phlegm dissipation, and blood stasis removal.28 Clinical studies have demonstrated that it exhibits the potential to ameliorate the symptoms of cerebral infarction, safeguarding the neurological function of convalescent patients, stimulating angiogenesis post-cerebral infarction, and reducing the volume of cerebral infarction.29,30 Further investigation has indicated that Compound Tongluo Decoction may impede ferroptosis induced by endoplasmic reticulum stress and facilitate angiogenesis through the activation of the Sonic Hedgehog pathway in rats with cerebral infarction.28
Naotaifang, a compound Chinese herbal medicine, comprises Radix Astragali, Rhizoma chuanxiong, Pheretima, and Bombyx batryticatus. Several studies have demonstrated the clinical efficacy of Naotaifang in enhancing nervous system function in patients suffering from acute cerebral ischemia.31,32 In their research, Lan et al33 observed that acute cerebral ischemia triggers neuronal ferroptosis, and the administration of Naotaifang to rats with middle cerebral artery occlusion resulted in the suppression of ferroptosis through activation of the TFR1 (transferrin receptor 1)/DMT1 (divalent metal transporter 1) and SCL7A11/GPX4 pathways.
Qishen Yiqi Dripping Pill is a TCM comprising four medicinal herbs, namely, Astragalus membranaceus Fisch. ex Bunge, Salvia miltiorrhiza Bge., Panax notoginseng (Burk.) F. H. Chen, and Dalbergia odorifera T. Chen.34 The National Medical Products Administration approved its use in 2003 for the clinical treatment of ischemic heart diseases. In their study, Wu et al35 discovered that Qishen Yiqi Dripping Pill has the potential to alleviate myocardial ischemia-induced ferroptosis by enhancing mitochondrial biogenesis and dynamic homeostasis.
Traumatic diseases
Niujiaodihuang Detoxify Decoction (NDD), an integrated TCM prescription, has been used as a therapeutic intervention for acute liver failure (ALF). It comprises nine botanical ingredients, namely, Cornu Bubali, Paeonia lactiflora Pall, Rehmannia glutinosa, Artemisia anomala S. Moore, Artemisia capillaris Thunb, Gentiana macrophylla Pall, Paeoniae Alba Radix, Gardenia jasminoides J. Ellis, and Glycyrrhiza inflata Batalin. Ji et al36 conducted a study demonstrating its effectiveness in alleviating liver injury induced by lipopolysaccharide. Subsequent investigations have revealed that Niujiaodihuang Detoxify Decoction exerts hepatoprotective effects by modulating the reprogramming of GSH metabolism, thereby inhibiting the progression of liver injury.36
Wenqingyin, derived from the renowned TCM text “Rejuvenation of All Diseases”, has been extensively utilized by medical practitioners for the treatment of diverse infectious ailments. Its composition includes Coptidis Rhizoma, Phellodendri Cortex, Gardeniae Fructus, Scutellaria Radix, Rehmanniae Radix Preparata, Paeoniae Alba Radix, Angelicae Sinensis Radix, and Chuanxiong Rhizoma in equimolar proportions. Xie et al37 conducted a study demonstrating the potential of Wenqingyin in ameliorating liver injury induced by lipopolysaccharide. Further study has demonstrated that Wenqingyin effectively inhibits ferroptosis during the development of lipopolysaccharide-induced liver injury by activating the Nrf2-mediated signaling pathway.37
Derived from the TCM formulations of Dachaihu Decoction and Dachengqi Decoction in the Treatise on Cold Damage Diseases compiled by Zhongjing Zhang, Qingyi Decoction (QYD) is frequently used in the treatment of individuals suffering from acute pancreatitis due to its purgative properties and ability to eliminate fever and toxic substances.38 In this study, its active ingredients were examined using network pharmacology to identify its primary molecular targets and targeted signaling pathways in the context of severe acute pancreatitis-associated acute lung injury. Rescue experiments were conducted to establish the association between Qingyi Decoction and ferroptosis. The findings of this study suggest that Qingyi Decoction has the potential to inhibit ferroptosis by enhancing ALDH2 (aldehyde dehydrogenase 2) expression and to mitigate neutrophil infiltration by inhibiting the cleavage of intact AnxA1 (annexin A1) and by down-regulating ICAM1 (intercellular adhesion molecule 1) expression.39
Xiaojianzhong Decoction, a TCM compound comprising cassia twig, Paeonia lactiflora, liquorice, ginger, jujube, and maltose, has been widely recognized for its therapeutic effects on stomach diseases for over two millennia. A recent study demonstrated its significant efficacy in mitigating aspirin-induced gastric mucosal injury and suppressing oxidative stress and ferroptosis in mice.40 Subsequent investigations have suggested that the mechanism underlying this protective effect involves the inhibition of aspirin-induced oxidative stress and ferroptosis through the p62/Keap1 (Kelch-like ECH-related protein 1)/Nrf2 signaling pathway, ultimately leading to the amelioration of gastric mucosal injury.40
TCM monomers that can regulate ferroptosis
The material basis of TCM treatment of diseases is its active pharmaceutical components. The chemical structure of a component plays a significant role in determining its physical and chemical properties, as well as its absorption, distribution, metabolism, and excretion within the body. Consequently, we classified the active components of TCM, including glycosides, phenylpropanoids, quinoid compounds, flavonoids, terpenoids, organic acids, alkaloids, and other compounds, based on their respective chemical structures. Figure 2 illustrates the chemical structure of the TCM monomers.
Figure 2.
Chemical structure of the monomer.
Glycosides
Glycosides, also referred to as ligands, are compounds resulting from the linkage of the terminal carbon atom of a sugar or sugar derivative with another class of non-sugar substances (aglycones, ligands). Glycosides are widely distributed throughout the plant kingdom, particularly in higher-order plants.
Polyphyllin
Paris polyphylla is a highly useful medicinal plant that is primarily found in the Sichuan and Yunnan provinces of China. Saponins are the primary active substances of the plant. Investigations regarding tumors frequently examine saponins such as polyphyllin I (PPI), polyphyllin III (PPIII), and polyphyllin VI (PPVI).41 Zhou et al42 explored the anti-cancer effects of PPIII on MDA-MB-231 human breast cancer cells both in vitro and in vivo and revealed that PPIII exerted anti-cancer activities mainly through ACSL4-mediated lipid peroxidation activation and ferroptosis induction. PPVI has demonstrated potent anti-cancer effects in various malignant tumors. A recent study revealed that PPVI effectively inhibited the proliferation, migration, and invasion of hepatocellular carcinoma cells by potentially targeting the STAT3 (signal transducer and activator of transcription 3)/GPX4 axis to induce ferroptosis.43
Salidroside
Salidroside, a p-hydroxyphenyl-β-glucoside compound, is distributed in all parts of Rhodiola rosea L. and has various biological activities and a wide spectrum of pharmacological properties. Yang et al44 revealed that salidroside plays a neuroprotective role by inhibiting neuronal ferroptosis in mice with Aβ1−42-induced Alzheimer’s disease and in Glu-injured HT22 cells, and its mechanism is related to activation of the NRF2/HO1 signaling pathway. Next, the researchers used SAMP8 (senescence-accelerated mouse prone 8) mice as Alzheimer’s disease models and treated them with salidroside. The administration of salidroside decreased iron deposition, reduced TFR1 and ACSL4 protein expression, and up-regulated SLC7A11 expression. Further experiments suggested that salidroside alleviates cognitive impairment and inhibits neuronal ferroptosis. The underlying mechanisms may involve Nrf2/GPX4 axis activation and a reduction in CD8+ T-cell infiltration.45
Sulforaphane
Sulforaphane, a compound found in broccoli and in broccoli sprouts that is transformed from a significant glucosinolate, has been demonstrated to decrease the development of preexisting tumors and to prevent chemically produced malignancies in animal models.46 Sulforaphane prevents environmental carcinogens from harming cells and causes growth arrest and/or apoptosis in numerous cancer cell types.47 According to Wang et al,48 ferroptosis was observed in the hearts of type 2 diabetic mice with diabetic cardiomyopathy. By increasing ferritin and SLC7A11 levels, sulforaphane-activated NRF2 prevented cardiac cell ferroptosis in both advanced glycation end-product-treated engineered cardiac tissues and hearts of diabetic cardiomyopathy mice. Moreover, AMPK (AMP-activated protein kinase) was required for sulforaphane’s inhibitory action on ferroptosis. This evidence shows that sulforaphane inhibits ferroptosis via the AMPK/NRF2 pathways.48
Phenylpropanoids
Phenylpropanoids are a group of natural organic compounds with one or more C6–C3 units in the basic parent nucleus, including simple phenylpropanoids (phenylpropylene, phenylpropanol, phenylpropanal, phenylpropionic acid, etc.), coumarins, and lignans. The existence of phenylpropanoids is related to the regulation of plant growth and resistance to disease. It is a highly significant class of natural substances that exhibits a wide variety of biological activities.
Ferulic acid
Ferulic acid is a common phenolic acid in plant cell walls. It forms a cross-linked component of the cell wall together with lignin and polysaccharide. It is one of the effective components of various TCMs, such as Ferula, Angelica sinensis, Chuanxiong, and cohosh. Ferulic acid is highly effective at scavenging ROS and activating anti-oxidant enzymes, which are crucial in preventing the development of diabetes, cardiovascular disease, and cancer.49, 50, 51 Liu et al52 discovered that ferroptosis contributed to rat myocardial ischemia–reperfusion damage. According to their research, ferulic acid reduced ROS overproduction, promoted GSH production, blocked Ptgs2 (prostaglandin-endoperoxide synthase 2) mRNA and Fe2+ accumulation, decreased LDH (lactate dehydrogenase) and CK (creatine kinase) activities, attenuated myocardial infarction, and improved ischemia–reperfusion-induced ferroptosis. It also improved oxidative stress and decreased ROS overproduction. The prospect of creating medications containing ferulic acid to prevent cardiac problems is encouraging.52
Psoralidin
One of the main coumarins found in Psoralea corylifolia L. seeds, psoralidin, has been utilized as an alternative treatment for numerous illnesses, including depression, inflammatory diseases, and cardiovascular illnesses.53 In a study by Yaseen et al,54 MeOH fruit extract of C. corylifolium was used to isolate psoralidin, which was then further purified by preparative high-performance liquid chromatography. Psoralidin inhibited ferroptosis in HT22 mouse hippocampal cells exposed to erastin. Additionally, a molecular docking assay revealed that psoralidin might bind to two putative ferroptosis targets: 5-LOX (5-lipoxygenase) and the interface of Keap1-Nrf2 interaction. These results suggest that psoralidin may have therapeutic promise in the management of disorders associated with ferroptosis.54
Schisandrin A
Schisandrin A is a lignan extracted from the dried fruits of Schisandra chinensis, a traditional Chinese functional food. It has a variety of pharmacological effects on immune control, apoptosis inhibition, and anti-oxidation.55, 56, 57, 58 Wang et al59 established in vitro and in vivo models: streptozotocin was administered to C57BL/6 mice following a high-fat diet to induce diabetes. d-glucose (20 mmol/L) was used to activate human renal glomerular endothelial cells to construct a diabetic nephropathy model. They investigated the function of schisandrin A in both models and discovered that it attenuated ferroptosis in diabetic nephropathy via AdipoR1/AMPK-ROS/mitochondrial damage.59
Quinoids
Quinoid compounds are natural organic compounds that have an unsaturated cyclodione structure (quinoid structure) within the molecule or are easily transformed into such a structure. Quinones are the active constituents in many natural remedies, including rhubarb, Polygonum multiflorum, Polygonum polygonum, aloe vera, and salviorrhiza. Quinones are mostly found in the metabolites of Polygonaceae, Rubiaceae, Liliaceae, legumes, and other higher-order plants. Quinones are a promising family of natural medicines with potential anti-oxidant, anti-inflammatory, anti-bacterial, diuretic, and hemostatic effects.
Resveratrol
Resveratrol mainly exists in veratrum pilosa, knotweed, grape, and other plants, and it has immune regulatory, anti-oxidant, anti-inflammatory, myocardial protective, and other biological properties.60, 61, 62, 63 Researchers have found that in oxygen–glucose deprivation/reoxygenation-induced H9c2 cells and ischemia–reperfusion rats, resveratrol reduced ferroptosis, decreased TFR1 expression, and elevated the expression of FTH1 (ferritin heavy chain 1) and GPX4. Additionally, they discovered that resveratrol prevented ferroptosis through the control of USP19 (ubiquitin-specific peptidase 19)/Beclin1 autophagy.64
Tanshinone IIA
Tanshinone IIA is the active ingredient extracted from Salvia miltiorrhiza, which has anti-angiogenic, anti-oxidant, anti-inflammatory, immunomodulatory, and anti-cancer properties and is recognized as a traditional medicine in China.65, 66, 67, 68, 69 Through the detection of spheroid formation, flow cytometry analysis, and the expression of stem cell markers (OCT3/4, ALDH1A1, and CD44), Ni et al70 discovered that tanshinone IIA might lower gastric cancer cell stemness. According to further analysis, it increased lipid peroxide levels and lowered GSH levels in gastric cancer cells, both of which are indicators of ferroptosis. Moreover, the expression of a ferroptosis inhibitor (Fer-1) or overexpression of SLC7A11, a crucial ferroptosis inhibitor, abolished the inhibitory effects of tanshinone IIA on gastric cancer cell stemness. Thus, tanshinone IIA partially caused ferroptosis, which decreased the stemness of gastric cancer cells.70
Chrysophanol
The primary anthraquinone in rhubarb, chrysophanol, prevents myocardial ischemia and improves lipid metabolism while also having anti-inflammatory, anti-cancer, and neuroprotective properties.71,72 In two separate oral cancer cell lines, FaDu, a hypopharyngeal squamous cell carcinoma cell line, and SAS, a poorly differentiated squamous cell carcinoma cell line from a primary lesion on the human tongue, Lin et al73 evaluated the pharmacological effects of chrysophanol on ferroptosis. The findings showed that chrysophanol boosted the levels of lipocalin-2 and CHOP and lowered the levels of GPX4 and lipid ROS. These results imply that chrysophanol has the therapeutic potential to slow the development of oral carcinogenesis by inducing ferroptosis.73
Flavonoids
Flavonoids have a basic skeleton made up of the carbon atoms C6–C3–C6 and consisting of 15 carbon atoms.74 Depending on the different substituents on the carbon backbone, flavonoids can be categorized into various subclasses.75 They are widespread in nature and typically found in many plant components, particularly in flowers and leaves. Flavonoids have anti-inflammatory, anti-neoplastic, anti-bacterial, anti-oxidant, anti-viral, and other biological actions.76, 77, 78, 79, 80
Baicalin
Baicalin (7-glucuronic acid-5,6-dihydroxy-flavone) is a lipophilic flavonoid glycoside isolated from Scutellaria root that possesses strong biological activities. When H9c2 cells were treated with oxygen–glucose deprivation/reoxygenation, increased lipid peroxidation, significant iron accumulation, activated TfR1 (transferrin receptor protein 1) signaling, and NCOA4 (nuclear receptor coactivator 4)-mediated ferritinophagy were observed. These effects were all reversed by baicalin treatment, according to research by Fan et al.81 Additionally, the protective effect of baicalin produced in H9c2 cells was weakened by the overexpression of ACSL4. They concluded by saying that baicalin protects against myocardial ischemia/reperfusion injury by decreasing ACSL4-controlled ferroptosis.81 Moreover, baicalin has been reported to reduce iron deposition in liver, kidney, and brain tissues while improving neural dysfunction by inhibiting ferroptosis in brain tissues.82, 83, 84
Proanthocyanidins
Natural flavonoids have been demonstrated to be able to stop illnesses caused by lipid peroxidation and inflammation. Safflower (Carthamus tinctorius L.) contains flavonoids called proanthocyanidins that have anti-viral, anti-inflammatory, and anti-oxidant properties.85,86 To assess the defense function of proanthocyanidins against influenza A virus-induced acute liver injury and its potential mechanism, Lv et al87 used a mouse model of acute liver injury caused by the nasal injection of influenza A virus. When proanthocyanidins are administered, GPX4 and SLC7A11 expression are up-regulated, ACSL4 expression is down-regulated, GSH levels are restored, redox equilibrium is preserved, and anti-oxidative effects are strengthened. Proanthocyanidins can therefore prevent ferroptosis to treat influenza A virus-induced acute liver injury.87 Anthocyanins such as cyanidin-3-glucoside belong to a characteristic class of soluble flavonoids. Both in vitro and in vivo, cyanidin-3-glucoside had an inhibitory effect on ferroptosis, which was characterized by the reduction in excessive intracellular free iron accumulation, a reduction in 4HNE (4-hydroxy-2-nonenal) accumulation, lipid ROS, malondialdehyde levels, and ACSL4 expression, and an increase in GPX4 expression and GSH levels.88
Quercetin
Quercetin has been associated with several advantageous physiological processes, including those with anti-oxidant, anti-diabetic, anti-cancer, and anti-inflammatory benefits.89, 90, 91, 92, 93 Multiple low-dosage injections of streptozocin were used to create a type 2 diabetes mouse model, which was then treated for four months with quercetin. Research shows that ferroptosis is a factor in pancreatic β cell dysfunction and loss. However, quercetin may reduce pancreatic iron deposition and pancreatic β cell ferroptosis, hence reducing the risk of type 2 diabetes.94
Terpenoids
Terpenoids are chemical substances and their derivatives that are generated from meglutaric acid and have the isoprene unit as their fundamental structural unit. Chinese herbs, fruits, vegetables, and whole grains all contain terpenoids in large quantities. They are a class of metabolites that are abundantly present in plants. Terpenes serve a variety of critical ecological roles in controlling how plants interact with their surroundings. Certain terpenes are essential for plant growth and development, and other terpenes have crucial biological functions.
Artemisinin and artesunate
Artemisinin is a sesquiterpene lactone compound found in Artemisia annua (Asteraceae). It was first discovered in 1971 by the Nobel Prize-winning Chinese chemist Youyou Tu. Artemisinin compounds have unique oxygen bridge structures, have significant therapeutic effects on malaria, and do not easily produce drug resistance.57 Dihydroartemisinin and artesunate, its derivatives, have both been approved by the US Food and Drug Administration, and it is well acknowledged that they have pharmacological action.95, 96, 97
Artesunate is a water-soluble form of artemisinin. In addition to having potent anti-malarial, anti-parasitic, anti-viral, and other actions, artesunate also has considerable anti-tumor effects.97, 98, 99, 100, 101, 102 In vitro tests performed by Lee et al103 on CX1, LS174T, and HCT116 human colon cancer cells revealed that 15 mg/kg artesunate could dramatically reduce the expression of DR5 (death receptor 5), Bax (Bcl-2-associated X protein), and Bak (Bcl-2 homologous antagonist killer) as well as suppress tumor development. The process is associated with the up-regulation of DR5 and the improvement of ferroptotic cell susceptibility to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis.103 Related research has demonstrated that artesunate can control the degree of ferroptosis in tumor cells such as ovarian cancer cells, ovarian serous carcinoma cells, and Burkitt’s lymphoma cells.104, 105, 106
Dihydroartemisinin, which is produced from artemisinin by reducing sodium tetrahydroboronate, has the benefits of being more water soluble, having a fast metabolism, being quickly absorbed, being widely available, and having good anti-malarial action.107 By binding to cell-free iron, dihydroartemisinin can promote the binding of iron regulatory proteins to messenger RNA molecules that contain iron-responsive element sequences. As a result, it can interfere with the iron homeostasis process that is regulated by iron regulatory proteins and iron response elements.108 According to Du et al,109 dihydroartemisinin accelerates ferritin degradation, increases the unstable iron pool, encourages the formation of ROS in cells, and ultimately causes ferroptosis in acute myeloid leukemia cells by controlling the activity of the AMPK/mTOR (mammalian target of rapamycin)/p70S6k signaling pathway.109
Cucurbitacin B
Cucurbitacin B, one of the most prevalent and extensively investigated cucurbitacin derivatives, is isolated from Trichosanthes kirilowii Maximowicz.110 It has proven potent anti-bacterial, anti-fungal, anti-pyretic, and anti-cancer properties that are applied in conventional medicine by controlling numerous signaling pathways.111, 112, 113 Huang et al114 showed that cucurbitacin B causes cell death via the ferroptosis pathway. The precise mechanism involves cucurbitacin B stimulation of the buildup of iron ions and the depletion of GSH levels, which leads to the overabundance of lipid peroxides. Additionally, cucurbitacin B inhibits GPX4 expression, which initiates a multifaceted ferroptosis pathway in CNE1 cells.114
Deoxyelephantopin
Deoxyelephantopin is a plentiful sesquiterpene lactone that was discovered in Elephantopus scaber, a well-known perennial herb that has been used traditionally to cure hepatitis, infection, and diuresis.115,116 Chang et al117 discovered that deoxyelephantopin and its derivative DETD-35 are a novel GPX4 enzyme inhibitor that exerts its effect through noncovalent binding. By altering GSH levels and primary metabolism, lipid/oxylipin metabolism, and mitochondrial damage, deoxyelephantopin and DETD-35 caused lipid ROS buildup and triggered ferroptotic cell death in PLX4032-sensitive (A375) and PLX4032-resistant (A375-R) BRAF V600E melanoma cells.117
Organic acids
Organic acids are a class of acidic organic chemicals that are commonly found in plants and include carboxyl groups. They are widely distributed in the leaves, roots, and notably the fruits of Chinese herbal medicine, where they primarily manifest as salts, fats, lipids, waxes, etc. Some of these substances have a role in the metabolism of animals and plants, while others are metabolic intermediates, exhibit important biological functions, or serve as raw materials for the pharmaceutical industry.
Oleanolic acid
Oleanolic acid is a pentacyclic triterpene that is found naturally in plant leaves, fruits, and seeds.118 Numerous biological actions, including anti-oxidant, anti-inflammatory, and anti-tumor actions, have been linked to oleanolic acid.119, 120, 121 HeLa cells were used as the cellular model and tumor-bearing mice as the animal model in a study by Jiang et al.122 Oleanolic acid increased the levels of oxidative stress and Fe2+ content as well as the expression of proteins involved in ferroptosis in both in vivo and in vitro experiments. ACSL4 was also significantly up-regulated in cervical cancer (HeLa) cells and xenograft models after oleanolic acid therapy. Following the administration of siRNA to reduce ACSL4 expression in cervical cancer cells, the inhibitory effect of oleanolic acid on cell survival and proliferative capability was reversed, and a decrease in ROS levels and GPX4 was found. This finding implies that oleanolic acid decreases the survival rate of HeLa cells by promoting ACSL4 expression and activating ferroptosis in HeLa cells.122
Gambogenic acid
Gambogenic acid, an active constituent of gamboge, a gum-resin extract of Garcinia hanburryi tree, is a TCM compound with excellent anti-cancer properties and regulatory effects on inflammatory and apoptosis pathways.123,124 Wang et al125 discovered that gambogenic acid greatly reduced the invasion, migration, and epithelial–mesenchymal transition of melanoma cells. These cells also had minor mitochondrial wrinkling, which is a crucial component of ferroptosis. Gambogenic acid increased the expression of the enzymes p53, GPX4, and SLC7A11, which contribute to the processes underlying gambogenic acid-induced ferroptosis. Moreover, their research points to the possibility that gambogenic acid triggers ferroptosis in TGF-1 (transforming growth factor 1)-stimulated melanoma cells through signaling via the p53/SLC7A11/GPX4 pathway.125
Glycyrrhetinic acid
Glycyrrhetinic acid, also known as 18-β-glycyrrhetinic acid, is one of the primary active ingredients that has been identified from liquorice. Numerous pharmacological actions of glycyrrhetinic acid include anti-inflammatory, anti-tumor, anti-viral, and anti-oxidative properties.126, 127, 128, 129 Wen et al130 examined cell viability, apoptosis, and ferroptosis in MDA-MB-231 cells to demonstrate the anti-cancer effects of glycyrrhetinic acid. In MDA-MB-231 cells, glycyrrhetinic acid treatment boosted the expression and activity of NADPH oxidase and iNOS (inducible nitric oxide synthase) as well as the formation of ROS/reactive nitrogen species. Meanwhile, glycyrrhetinic acid reduced GSH levels, inhibited GPX function and down-regulated the expression of SLC7A11. Together, NADPH oxidases, iNOS, and decreased GSH and GPX activity might help glycyrrhetinic acid increase the generation of ROS and reactive nitrogen species, which then exacerbates lipid peroxidation and causes ferroptosis in triple-negative breast cancer cells.130
Alkaloids
Alkaloids are a group of naturally occurring chemical compounds that are extensively present in plants, including those belonging to the families Berberidaceae, Lycoraceae, Thyraceae, and Solanaceae. All alkaloids include at least one basic nitrogen atom inserted into their ring structure. The biological effects of alkaloids are diverse, and in recent years, research on their anti-tumor properties has grown significantly.
Solasonine
Solasonine, a steroidal alkaloid, is derived from Solanum nigrum L., a traditional Chinese herb. Numerous anti-tumor properties of solasonine have been discovered, including those that protect against lung cancer, bile duct cancer, and bladder cancer.131, 132, 133 Solasonine’s effects were studied in vitro and in vivo using pancreatic cancer cells (PANC-1 and CFPAC-1). Solasonine participates in ferroptosis by inhibiting the transcriptional up-regulation of OTUB1 (OTU deubiquitinase, ubiquitin aldehyde binding 1) mediated by TFAP2A (transcription factor AP-2 alpha), which in turn activates the ubiquitination-mediated degradation of SLC7A11 and encourages ferroptosis in pancreatic cancer cells. In summary, solasonine inhibits the TFAP2A/OTUB1/SLC7A11 axis to stimulate ferroptosis and prevent the spread of pancreatic cancer cells.134
Berberine
Berberine is derived from the root of the natural plant Coptis chinensis. Alkaloids are extracted from the stem and have therapeutic properties, including anti-oxidative stress, hypoglycemic, and neuroprotective properties.135, 136, 137 In mice treated with berberine, the characteristic morphological alterations in ferroptotic cells and indicators of ferroptosis were mitigated, along with decreased malondialdehyde and ROS levels and increased GSH levels. In mice with cerebral ischemia‒reperfusion injury, berberine changed the composition of the gut flora, and antibiotics interfered with the protective effects of berberine. Based on the 16S rRNA data, KEGG analysis showed that berberine affected several metabolic pathways, including those involved in ferroptosis and GSH metabolism. This study raises the possibility that berberine can influence these pathways by modulating the microbiome to counteract ferroptosis caused by cerebral ischemia‒reperfusion injury and thereby demonstrate neuroprotective effects.138
Leonurine
Leonurine, also named SCM-198, is extracted from the leaves of Chinese motherwort and has been reported to be protective against various cardiovascular and brain diseases.139,140 Leonurine hydrochloride can be used as a quality marker for motherwort identification and content estimation. In cisplatin-induced acute kidney damage, leonurine hydrochloride activated the Nrf2 antioxidative pathway, therefore protecting against alterations in ferroptosis-related morphological and biochemical markers, including malondialdehyde levels, superoxide dismutase and GSH depletion, and GPX4 and xCT down-regulation. However, in Nrf2 knockout mice, the protective effects of leonurine hydrochloride on acute kidney damage and ferroptosis were virtually eliminated. These findings indicate that lipid peroxide-mediated ferroptosis is at least partially inhibited to accomplish the renoprotective effects of Nrf2 activation on cisplatin-induced acute kidney damage.141 Similarly, a study demonstrated leonurine’s hepatoprotective efficacy against iron-induced hepatotoxicity, which may be achieved by altering Nrf2 and NF-κB signaling.142
Others
There are structural types with fewer member compounds in addition to the above categories, and these structures cannot be classified using the categories indicated above.
Bicyclol
Schisandra chinensis, a TCM, is the source of bicyclol, an innovative product pioneered in China. Bicyclol has several therapeutic benefits, including the prevention of viral replication, the reduction in oxidative stress, the prevention of fibrosis, the prevention of liver damage, and the promotion of protein synthesis in hepatocytes.143,144 In a study by Zhao et al,145 CCL4 (C–C motif chemokine ligand 4) induced iron accumulation, excessive production of ROS, increased lipid peroxidation, and distinctive morphological changes in mitochondria. Additionally, it resulted in a decrease in the levels of the proteins GPX4 and xCT in the livers of mice with acute liver injury, all of which are signs of ferroptosis. By favorably modulating the Nrf2/GPx4 axis to halt the aforementioned ferroptotic process, bicyclol protects the liver.145
Astragalus polysaccharide
Astragalus polysaccharide (APS) is a natural bioactive substance found in Astragalus membranaceus, the root of Astragalus membranaceus (Fisch.) Bge., or Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao.146 Its potential pharmaceutical effects include anti-cancer effects, radiation protection, immune system regulation, and gut microbiota modulation.147, 148, 149, 150 Chen et al151 found that astragalus polysaccharide treatment clearly inhibited ferroptosis in both dextran sulfate sodium-challenged mice and RSL3 (RAS-selective lethal 3)-stimulated Caco-2 cells, as demonstrated by a reduction in the expression of genes associated with ferroptosis (prostaglandin-endoperoxide synthase 2, ferritin light chain, and ferritin heavy chain) and the levels of surrogate ferroptosis markers (malondialdehyde, GSH, and iron accumulation). Their research revealed a novel function for astragalus polysaccharide in blocking the NRF2/HO1 pathway, which prevents ferroptosis in a murine model of experimental colitis and in human Caco-2 cells.151
β-Elemene
β-Elemene is a powerful substance derived from the natural medicinal plant Zedoary turmeric. It is a tiny molecule and anti-tumor phytochemical medication discovered in China.152 Studies have shown that β-elemene can inhibit tumor growth by inducing apoptosis, limiting cell invasion and metastasis, and preventing new angiogenesis while also enhancing the function of the immune system.153,154 In KRAS mutant colorectal cancer cells, Chen et al155 showed that β-elemene and cetuximab caused iron-dependent ROS accumulation, GSH depletion, lipid peroxidation, up-regulation of HO1 and transferrin expression, and down-regulation of negative ferroptosis regulatory protein expression (GPX4, SLC7A11, FTH1, glutaminase, and SLC40A1). The effect was eliminated by ferroptosis inhibitors but not by other cell death suppressors. The results indicated for the first time that the natural substance β-elemene is a novel inducer of ferroptosis.
To enhance comprehension, a schematic diagram illustrating the regulatory mechanism of ferroptosis by TCM monomers was created (Fig. 3).
Figure 3.
Significant traditional Chinese medicine (TCM) monomers involved in ferroptosis and their targets. OA, oleanolic acid; GA, glycyrrhetinic acid; PA, proanthocyanidin; GNA, gambogenic acid; TSA, tanshinone IIA.
Prospects
Historically, novel medications have come largely from natural sources. Youyou Tu, a Nobel laureate, was inspired by the Zhouhou Beiji Fang, a well-known monograph of TCM written by Hong Ge in the Eastern Jin dynasty, to create artemisinin, which was received as a beneficial new therapy worldwide. More than 40 representative Chinese medicine compounds (Table 1) and monomers (Table 2) that modulate ferroptosis are outlined in this review, along with their targets and modes of action. Based on the relationship between the structure and efficacy of most natural drugs, drugs of the same pharmacological action type that bind to a specific receptor often have some structural similarity. Therefore, we categorized the compounds according to their structural properties to increase the medicinal plant resources and to find novel bioactive chemicals (Table 3).
Table 1.
TCM compounds regulating ferroptosis.
| TCM compounds | Composition | Function | Disease | Mechanisms |
|---|---|---|---|---|
| Fuzheng Kang’ai decoction | Radix Pseudostellariae, Rhizoma Atractylodis Macrocephalae, Milkvetch Root, etc. | Inducer | Non-Small Cell Lung Cancer | Augment lipid peroxidation and abundance of intracellular Fe2+ ions, downregulated expression of GPX413 |
| Qing-rehuo-xue formula | Scutellaria baicalensis and Radix paeoniae rubra | Inducer | Non-Small Cell Lung Cancer | Regulate the p53 and GSK-3β/Nrf2 signalling pathways14 |
| Fuzheng Nizeng Decoction | Astragalus mongholicus Bunge, Astragalus mongholicus Bunge, Glycyrrhiza uralensis Fisch, etc. | Inducer | Gastric precancerous lesions | Downregulate GPX4/GSH levels; activation of ATF3/CHOP/CHAC1 signalling pathway16 |
| Shuganning injection | Ganoderma Lucidum, Isatidis Radix, Gardeniae Fructus, Artemisiae Scopariae Herba, and a flavone glycoside baicalin |
Inducer | Breast cancer | Upregulate the expression of HO-1/Nrf219 |
| DiDang Decoction | Rhubarb, Peach seed, Leech, and Gadfly | Inhibitor | Atherosclerosis and Hyperlipidaemia | Activate the HIF-1 signalling pathway22 |
| Qing-Xin-Jie-Yu Granule | Astragalus membranaceu, Salvia miltiorrhiza Bunge, Ligusticum striatum, etc. | Inhibitor | Atherosclerotic cardiovascular diseases | Inhibit GPX4/xCT signalling pathway24 |
| Fo-Shou-San decoction | Angelica sinensis and Ligusticum wallichii | Cognitive deficits | Modulate of the NRF2/HO-1 pathway25 | |
| Compound Tongluo Decoction | Radix Polygonum Multiflorum Preparata, the rhizome of Polygonatum sibiricum, the stem and leaf of seaweed, etc. | Inhibitor | Cerebral infarction | Upregulate the expression of GPX4, downregulate the expression of ACSL428 |
| Naotaifang | Radix Astragali, Rhizoma chuanxiong, Pheretima, and Bombyx batryticatus. | Inhibitor | Acute cerebral ischaemia | Modulate the TFR1/DMT1 and SCL7A11/GPX4 pathways33 |
| QiShenYiQi dripping pills | Astragalus membranaceus Fisch. ex Bunge, Salvia miltiorrhiza Bge., Panax notoginseng (Burk.) F. H, etc. | Inhibitor | Myocardial ischaemia | Enhance mitochondrial biogenesis and dynamic homeostasis35 |
| Niujiaodihuang Detoxify Decoction | Cornu Bubali, Paeonia lactiflora Pall, Rehmannia glutinosa, etc. | Inhibitor | Liver injury | ReprogramGSH metabolism36 |
| Wenqingyin | Coptidis Rhizoma, Phellodendri Cortex, Gardeniae Fructus, etc. | Inhibitor | Liver injury | Activate the Nrf2-mediated signalling pathway37 |
| Qingyi decoction | Bupleurum chinense DC, Corydalis yanhusuo, Scutellaria baicalensis Georgi, etc. | Inhibitor | Acute lung injury | Enhance ALDH2 expression and downregulate ICAM-1 expression39 |
| Xiaojianzhong decoction | Cassia twig, Paeonia lactiflora, licorice, ginger, jujube, and maltose | Inhibitor | Gastric mucosal injury | Modulate the p62/Keap1/Nrf2 signalling pathway40 |
The Pharmacopoeia of the People’s Republic of China (version 2020) provided the names of these TCMs in both English and Chinese.
Table 2.
Representative monomers of TCMs regulating ferroptosis.
| TCMs or active pharmaceutical ingredients | Herbal Chinese name | Concentration | Function | Cell Types | Possible targets or mechanisms |
|---|---|---|---|---|---|
| PPIII | Chong lou | 5 μM | Inducer | MDA-MB231 breast-carcinoma cells | ACSL4-mediated lipid peroxidation elevation42 |
| PPⅥ | Chong lou | 4 μM | Inducer | HCCLM3 and Huh7 cells | Inhibited the STAT3/GPX4 axis43 |
| Salidroside | Hong jing tian | 40 μM | Inhibitor | HT22 cells | Activated of the Nrf2/HO1 signalling pathway activated the Nrf2/GPX4 axis44 |
| Sulforaphane | Gan lan | 10 μM | Inhibitor | Neonatal mouse ventricular cardiac cells | AMPK-mediated NRF2 activation48 |
| Ferulic acid | Dang gui | 100 mg/kg | Inhibitor | Rat myocardial cells | Reduced ROS overproduction52 |
| Psoralidin | Bu gu zhi | 5.21 μM | Inhibitor | HT22 cells | Binds to 5-LOX, and the interface of Nrf2-Keap1 interaction54 |
| Schisandrin A | Wu wei zi | 50 μM | Inhibitor | Human renal glomerular endothelial cells | Activated AdipoR1/AMPK-ROS/mitochondrial damage59 |
| Resveratrol | Li lu | 10 μM | Inhibitor | H9c2 cells | Downregulated of USP19/Beclin1-induced autophagy64 |
| Tanshinone IIA | Dan shen | 250 μM | Inducer | SGC-7901 and BGC-823 cells | Increased the level of lipid peroxides and decreased GSH level70 |
| Chrysophanol | Da huang | 7.5 μM | Inducer | FaDu and SAS HNSCC cells | Lowered levels of GPX4 and lipid ROS73 |
| Baicalin | Huang qin | 25 μM | Inhibitor | H9c2 cells | Suppressed ACSL4 overexpression81 |
| Proanthocyanidins | Hong hua | 20 mg/kg/day | Inhibitor | Alveolar epithelial cells | Modulates the TGF-β1/Smad2/3 pathway87 |
| Cyanidin-3-glucoside | Sang shen | 50 μM | Inhibitor | HK-2 and NRK-52E cells | Activated the AMPK pathway88 |
| Quercetin | Huai mi | 50 μM | Inhibitor | INS-1 cells | Upregulated the levels of GSH and GPX494 |
| Artesunate | Huang hua hao | 15 mg/kg | Inducer | CX1, LS174T, and HCT116 cells | Improved TRAIL-induced apoptosis sensitivity of ferroptotic cells103 |
| Dihydroartemisinin | Huang hua hao | 10 μM | Inducer | HL60, KG-1 and THP-1 cells | Modulated the AMPK/mTOR/p70S6k signalling pathway109 |
| Cucurbitacin B | Gua lou | 50 nM | Inducer | CNE1 cells | Encouraged the buildup of iron ions and the depletion of GSH, as well as inhibited GPX4 expression114 |
| Deoxyelephantopin | Di dan cao | 2.5 μM | Inducer | A-375 cells | Upregulated the levels of ROS117 |
| Oleanolic acid | Nv zhen zi | 5 μM | Inducer | HeLa cells | Promoted ACSL4 expression122 |
| Gambogenic acid | Teng huang | 1 μM | Inducer | A-375 and A-2058 cells | Modulated the p53/SLC7A11/GPX4 pathway125 |
| Glycyrrhetinic acid | Gan cao | 40 μM | Inducer | MDA-MB-231 cells | Induced ROS/RNS production, and increased lipid peroxidation.130 |
| Solasonine | Long kui | 50 μM | Inducer | PANC-1 and CFPAC-1 cells | Inhibited the TFAP2A/OTUB1 SLC7A11 axis134 |
| Berberine | Huang lian | 100 mg/kg | Inhibitor | Gut microbiota | Modulated the microbiome138 |
| Leonurine | Yi mu cao | 100 μM | Inhibitor | HK-2 cells | Partially inhibited lipid peroxide141 |
| Bicyclol | Wu wei zi | 10 μM | Inhibitor | L-02 cells | Positively regulated Nrf2-GPx4 axis145 |
| Astragalus polysaccharide | Huang qi | 50 μg/ml | Inhibitor | Caco-2 cells | Blocked the NRF2/HO-1 pathway151 |
| β-elemene | E shu | 125 μg/ml | Inducer | HCT-116 and LoVo cells | Upregulated the levels of ROS155 |
The Pharmacopoeia of the People’s Republic of China (version 2020) provided the names of these TCMs in both English and Chinese.
Table 3.
Representative TCM monomers grouped based on molecular structural characteristics.
| Species | Molecular structure characteristics | TCM monomers |
|---|---|---|
| Glycosides | An end-group carbon atom from a sugar or sugar derivative attached to a different type of non-sugar material to generate a compound | PPIII42; PPVI43; Salidroside44; SFN48; Astragaloside IV158; Timosaponin AIII159; Ophiopogonin B160; Saikosaponin A161; α-Hederin162; curculigoside163; Ophiopogonin D164; Paeoniflorin165; polyphyllin Ⅱ166 |
| Phenylpropanoids | A family of naturally occurring compounds with three straight carbon chains (C6–C3) connecting the benzene ring | FA52; PSO54; Schisandrin A59; Esculetin167; Osthole168 |
| Quinoid | Any member of the group of chemical compounds that have either the cyclohexadienedione or cyclohexadienedimethylene structure | Res64; TSA70; CHR73; Cryptotanshinone169; Dihydroisotanshinone I170; 15, 16-Dihydrotanshinone I171; Shikonin172; Acetylshikonin173 |
| Flavonoids | The basic parent nucleus is 2-phenylchromogen | Baicalin81; PAs87; C3G88; QCT94; Icariside II174; Vitexin175; Chrysin176; Dihydromyricetin177; Galangin178; Baicalein179; Soybean isoflavones180; Calycosin181; Curcumin182; Ginkgetin183; Eriocitrin184; Isoorientin185; luteolin186 |
| Terpenoids | Their fundamental structural unit is the isoprene unit. | ART103; DHA109; CuB114; DET117; Rehmannioside A187; β-caryophyllene188; Curcumenol189; β-Carotene190; β-Elemenic Acid191; Celastrol192; Obacunone193 |
| Organic acids | Certain organic substances possessing acidic qualities | OA122; GNA125; GA130; Crocetin194; Ganoderic acid A195 |
| Alkaloids | Alkaloids are nitrogen-containing organic molecules. | Solasonine134; BBR138; Leonurine141; Sinapine196; Sanguinarine197; Tetrandrine198; Matrine199 |
| Others | These constructions cannot be categorized using the previously listed categories. | Bicyclol145; APS151; β-Elemene155; Bufotalin200; Cinobufotalin201; Neutral polysaccharide from Gastrodia elata202; Brusatol203; Erianin204; Andrographolide205 |
The Pharmacopoeia of the People’s Republic of China (version 2020) provided the names of these TCMs in both English and Chinese.
Before their functions in controlling ferroptosis had been investigated, the anti-oxidant properties of 11 of the 27 monomeric compounds were proposed. In Cisd2-deficient cardiomyocytes, ferulic acid substantially reduced oxidative stress-induced damage by enhancing catalase activity and by reducing endogenous ROS generation, as other researchers have shown in the past. According to a recent study, ferulic acid ameliorates oxidative stress, reduces ROS overproduction, promotes GSH production, and improves ischemia–reperfusion-induced ferroptosis. Vitamin K, also known as a natural vitamin with anti-oxidant effects, has recently been demonstrated to act as an anti-oxidant and to successfully inhibit ferroptosis.156 Since the defensive mechanisms against ferroptosis rely on cellular anti-oxidant systems to directly neutralize lipid peroxides, we can study a substance’s role and method in preventing ferroptosis considering its previously known anti-oxidant properties and get twice as much done with half the effort.
Natural products are a significant source of medicines since they exhibit original and varied structural features as well as distinctive biological activities.157 Natural medicines, nevertheless, can come with many drawbacks. For instance, due to their effective antimalarial properties and high absorption, artemisinin derivatives such as artemether and artesunate have displaced artemisinin as the most widely used anti-malarial medications in clinical practice. The structures of natural active compounds often need to be adjusted and improved since they might not be able to match the conditions necessary for drug production. Different approaches to chemical disposal are used depending on the molecular size and complexity of natural products. By analyzing the link between structure and activity, it is possible to extract pharmacophores, attain skeleton migration, and acquire novel molecular structures. Further, complex and large molecules can be structurally divided to remove unnecessary atoms, such as removing an extra chiral center while maintaining the structure and conformation required for binding to the target. Complete synthesis of a novel drug is often required for industrialization while safeguarding resources and the environment. This issue can be resolved using medicinal chemistry, resulting in new chemical entities with increased efficacy, drug resistance, and fewer harmful side effects, which will lower the cost of creating new leading compounds. The cycle of new medication research and development can be, in this way, accelerated.
We discovered that there was a significant variance in the ideal concentration of each monomer, even within the same molecular class. Both gambogenic acid and glycyrrhetinic acid belong to the class of organic acids, and the optimal concentrations are 1 μM and 40 μM, respectively. If we want to further investigate experimental pharmacology (animal studies) or clinical pharmacology (human studies), we must give priority to compounds with low concentrations. The incidence of pharmacological side effects or unpleasant responses rises dramatically due to a drug’s excessive concentration, which might harm the liver, kidneys, blood, and other systems. It is also noteworthy that different doses of the same substance have different pharmacological effects. As illustrated, tanshinone IIA (3–10 μM) was used to pretreat doxorubicin-damaged H9c2 cells and greatly reduced the production of ROS while raising the amount of intracellular GSH.66 By raising lipid peroxide levels and lowering GSH levels, both of which are signs of ferroptosis, tanshinone IIA (250 M) has the opposite impact on gastric cancer cells.70 The regulatory effects of the same substance on ferroptosis are completely opposite at different concentrations, and the specific reasons need to be further studied.
We found that several examples of monomers located in the original drug were also present in the compound. For example, Wenqingyin contains Radix scutellariae radix and Angelica sinensis, and Qishen Yiqi Dripping Pill contains Radix astragalus membranaceus and Radix salvia miltiorrhiza. The mechanisms of ferroptosis regulation by these monomers are different, and the mechanism changes when a different compound is formed. This phenomenon deserves further consideration. TCM is the result of real-world medical experience verified by five thousand years of practice. Many of the compounds have been repeatedly verified by countless people and in the treatment of countless diseases and have also been tested by more than 300 plagues from the Han dynasty to the Qing dynasty. However, even if the clinical effect is good, it is not widely recognized and applied in clinical practice due to the lack of sufficient evidence-based medicine. The pharmacological mechanisms of TCM compounds are mostly focused on a certain pathway, certain targets, or a certain type of functional activity in the treatment of diseases. With the help of these methods, researchers have partially revealed the mechanisms of multitarget drug action of TCM compounds at a certain level (the whole animal, organ, cell, or molecular level), but most of the studies are vague descriptions of the whole biological system before and after intervention or limited to a single target or a certain pathway and lack analysis at the system network level. In recent years, with the rise of new technologies such as systems biology and network pharmacology, the research and development of drug mechanisms and new drugs have been developed from the traditional research model of “single component, single target, single disease” to the direction of “multicomponent, multitarget, multipathway”. This provides a new idea for future research on the treatment of common diseases with similar multitarget TCM compounds.
Summary
This paper presents a comprehensive examination of the correlation between ferroptosis and TCM in the context of disease treatment. This investigation establishes that the modulation of ferroptosis serves as a therapeutic avenue for TCM, thereby having significant implications for the utilization and advancement of TCM. Within this study, the mechanisms, chemical compositions, and optimal concentrations of Chinese medicine in regulating ferroptosis are thoroughly summarized and analyzed, thereby offering valuable insights for the development of targeted drugs aimed at manipulating ferroptosis.
Funding
This study was supported by the National Natural Science Foundation of China (No. 82074171, 81700592).
CRediT authorship contribution statement
Shuai Liu: Visualization, Writing – original draft. Xianzhen Yang: Writing – review & editing. Sanxia Zheng: Writing – review & editing. Changjing Chen: Writing – review & editing. Lei Qi: Visualization, Writing – review & editing. Xiangdong Xu: Conceptualization. Denglu Zhang: Conceptualization, Writing – original draft.
Conflict of interests
The authors declared no conflict of interests.
Footnotes
Peer review under the responsibility of the Genes & Diseases Editorial Office, in alliance with the Association of Chinese Americans in Cancer Research (ACACR, Baltimore, MD, USA).
Contributor Information
Lei Qi, Email: qileilaura@163.com.
Xiangdong Xu, Email: xiangdongxu0818@163.com.
Denglu Zhang, Email: dlzhang01@163.com.
References
- 1.Dixon S.J., Lemberg K.M., Lamprecht M.R., et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072. doi: 10.1016/j.cell.2012.03.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Tang D., Chen X., Kang R., Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–125. doi: 10.1038/s41422-020-00441-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Zhang X., Yu Y., Lei H., et al. The Nrf-2/HO-1 signaling axis: a ray of hope in cardiovascular diseases. Cardiol Res Pract. 2020;2020 doi: 10.1155/2020/5695723. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Angeli J.P.F., Schneider M., Proneth B., et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–1191. doi: 10.1038/ncb3064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Abdalkader M., Lampinen R., Kanninen K.M., Malm T.M., Liddell J.R. Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci. 2018;12:466. doi: 10.3389/fnins.2018.00466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lei G., Zhuang L., Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381–396. doi: 10.1038/s41568-022-00459-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Liu J., Jiang G., He P., Du X., Hu Z., Li F. Mechanism of ferroptosis in traditional Chinese medicine for clinical treatment: a review. Front Pharmacol. 2023;13 doi: 10.3389/fphar.2022.1108836. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Stockwell B.R., Angeli J.P.F., Bayir H., et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285. doi: 10.1016/j.cell.2017.09.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Stockwell B.R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401–2421. doi: 10.1016/j.cell.2022.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Yang X.B., Chai X.S., Wu W.Y., et al. Gefitinib plus Fuzheng Kang’ai Formula in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a randomized controlled trial. Chin J Integr Med. 2018;24(10):734–740. doi: 10.1007/s11655-017-2819-8. [DOI] [PubMed] [Google Scholar]
- 11.Wu W.Y., Yang X.B., Deng H., et al. Treatment of advanced non-small cell lung cancer with extracorporeal high frequency thermotherapy combined with Chinese medicine. Chin J Integr Med. 2010;16(5):406–410. doi: 10.1007/s11655-010-0535-8. [DOI] [PubMed] [Google Scholar]
- 12.Zheng F., Zhao Y., Li X., et al. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib. J Ethnopharmacol. 2019;239 doi: 10.1016/j.jep.2019.111928. [DOI] [PubMed] [Google Scholar]
- 13.Zhao Y.Y., Yang Y.Q., Sheng H.H., et al. GPX4 plays a crucial role in Fuzheng Kang’ai decoction-induced non-small cell lung cancer cell ferroptosis. Front Pharmacol. 2022;13 doi: 10.3389/fphar.2022.851680. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Xu F., Zhang J., Ji L., et al. Inhibition of non-small cell lung cancer by ferroptosis and apoptosis induction through P53 and GSK-3β/Nrf2 signal pathways using Qingrehuoxue Formula. J Cancer. 2023;14(3):336–349. doi: 10.7150/jca.79465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Xin D., Hui Y., Hong C., Zhuo H.W., Shan S.Y., Hui X.X. Observation on the curative effect of Liujunzi modified decoction on chronic atrophic gastritis with spleen and stomach weakness with dysplasia. Chin J Integr Tradit West Med. 2021;29:691–695. [Google Scholar]
- 16.Chu Y.M., Wang T.X., Jia X.F., et al. Fuzheng Nizeng Decoction regulated ferroptosis and endoplasmic reticulum stress in the treatment of gastric precancerous lesions: a mechanistic study based on metabolomics coupled with transcriptomics. Front Pharmacol. 2022;13 doi: 10.3389/fphar.2022.1066244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Dou W., Li J., Zhang J., Zhang Y. Effect of shuganning injection combined with reduced glutathione on liver function and serum T lymphocytes in primary liver cancer patients after transcatheter arterial chemoembolization. Chin Med. 2013;13:1349–1352. [Google Scholar]
- 18.Gao H.T., Wang M.L., Chen X.B., Xu X.M. Clinical observation of compound glycyrrhizin combined with shuganning on hepatoprotective effect of hepatic arterial infusion chemoembolization for primary liver cancer. Chin Remedies Clin. 2013;13:1487–1488. [Google Scholar]
- 19.Du J., Wang L., Huang X., et al. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells. Phytomedicine. 2021;85 doi: 10.1016/j.phymed.2021.153551. [DOI] [PubMed] [Google Scholar]
- 20.Wang X.L. Efficacy of additive DiDang Tang in the treatment of vulnerable plaques in carotid atherosclerosis. Contemp Med Forum. 2020;18:187–188. [Google Scholar]
- 21.Zhang Z., Huang R.L., Xu M.J., Huang Y.B. Efficacy of additive DiDang Tang in the treatment of vulnerable plaques in carotid atherosclerosis. Tradit Chin Med J. 2010;9:42–45. [Google Scholar]
- 22.Wu X., Pan J., Yu J.J., et al. DiDang decoction improves mitochondrial function and lipid metabolism via the HIF-1 signaling pathway to treat atherosclerosis and hyperlipidemia. J Ethnopharmacol. 2023;308 doi: 10.1016/j.jep.2023.116289. [DOI] [PubMed] [Google Scholar]
- 23.Lai R.M., Liu Q.Y., Ju J.Q., Xu H. Study of Qingxin Jieyu formula for regulation of vulnerable atherosclerotic plaques by network pharmacology. Chin J Integr Med Cardio-Cerebrovasc Dis. 2021;19:3263–3267. [Google Scholar]
- 24.Zhang J., Wang X., Guan B., et al. Qing-Xin-Jie-Yu Granule inhibits ferroptosis and stabilizes atherosclerotic plaques by regulating the GPX4/xCT signaling pathway. J Ethnopharmacol. 2023;301 doi: 10.1016/j.jep.2022.115852. [DOI] [PubMed] [Google Scholar]
- 25.Wang J., Shi J., Xiao Y., et al. Fo-Shou-San ameliorates chronic cerebral hypoperfusion-induced cognitive impairment in mice by regulating NRF2/HO-1 pathway against ferroptosis. J Integr Neurosci. 2023;22(2):41. doi: 10.31083/j.jin2202041. [DOI] [PubMed] [Google Scholar]
- 26.Lu J., Guo P., Liu X., et al. Herbal formula Fo Shou San attenuates Alzheimer’s disease-related pathologies via the gut-liver-brain axis in APP/PS1 mouse model of Alzheimer’s disease. Evid Based Compl Alternat Med. 2019;2019 doi: 10.1155/2019/8302950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Wang F. 120 cases of acupuncture combined with foshousan in treatment of ICVD. China Foreign Med Treat. 2016;35:176–180. [Google Scholar]
- 28.Hui Z., Wang S., Li J., Wang J., Zhang Z. Compound Tongluo Decoction inhibits endoplasmic reticulum stress-induced ferroptosis and promoted angiogenesis by activating the Sonic Hedgehog pathway in cerebral infarction. J Ethnopharmacol. 2022;283 doi: 10.1016/j.jep.2021.114634. [DOI] [PubMed] [Google Scholar]
- 29.Hui Z., Zhang J.H., Shi M.L., Wang J.Q. The neuroprotection of compound Tongluo decoction on cerebral infarction in rats and its angiogenesis mechanism. Chin J Integr Med Cardio-Cerebrovasc Dis. 2018;16:153–158. [Google Scholar]
- 30.Hui Z., Zhang J.N., Zhang J.H., et al. Effects of Fufang Tongluo decoction on neurological function and vascular growth-related factors in patients with acute cerebral infarction. J Tradit Chin Med. 2018;59:1383–1385. [Google Scholar]
- 31.He Y.H., Hao X.Y., Ge J.W. Clinical studies on naotaifang in treating patients with cerebral infarction with deficiency of Qi and blood stasis in TCM. J Emerg Tradit Chin Med. 2001;10:319–334. [Google Scholar]
- 32.Liao J., Yang M., Shi Y.M., Yu Q.P., Huang J., Ge J.W. Naotai formula’s regulation effects on expression of iron transmembrane protein in hippocampus CA2 of cerebral ischemia rats. World Chin Med. 2016;11:592–596. [Google Scholar]
- 33.Lan B., Ge J.W., Cheng S.W., et al. Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. J Integr Med. 2020;18(4):344–350. doi: 10.1016/j.joim.2020.01.008. [DOI] [PubMed] [Google Scholar]
- 34.Han J.Y., Li Q., Pan C.S., Sun K., Fan J.Y. Effects and mechanisms of QiShenYiQi pills and major ingredients on myocardial microcirculatory disturbance, cardiac injury and fibrosis induced by ischemia-reperfusion. Pharmacol Res. 2019;147 doi: 10.1016/j.phrs.2019.104386. [DOI] [PubMed] [Google Scholar]
- 35.Wu L., Fan Z., Gu L., et al. QiShenYiQi dripping pill alleviates myocardial ischemia-induced ferroptosis via improving mitochondrial dynamical homeostasis and biogenesis. J Ethnopharmacol. 2023;308 doi: 10.1016/j.jep.2023.116282. [DOI] [PubMed] [Google Scholar]
- 36.Ji Y., Si W., Zeng J., et al. Niujiaodihuang Detoxify Decoction inhibits ferroptosis by enhancing glutathione synthesis in acute liver failure models. J Ethnopharmacol. 2021;279 doi: 10.1016/j.jep.2021.114305. [DOI] [PubMed] [Google Scholar]
- 37.Xie L., Zhou C., Wu Y., et al. Wenqingyin suppresses ferroptosis in the pathogenesis of sepsis-induced liver injury by activating the Nrf2-mediated signaling pathway. Phytomedicine. 2023;114 doi: 10.1016/j.phymed.2023.154748. [DOI] [PubMed] [Google Scholar]
- 38.Yang C., Wang T., Chen J., et al. Traditional Chinese medicine formulas alleviate acute pancreatitis: pharmacological activities and mechanisms. Pancreas. 2021;50(10):1348–1356. doi: 10.1097/MPA.0000000000001931. [DOI] [PubMed] [Google Scholar]
- 39.Ge P., Luo Y., Yang Q., et al. Ferroptosis in rat lung tissue during severe acute pancreatitis-associated acute lung injury: protection of Qingyi decoction. Oxid Med Cell Longev. 2023;2023 doi: 10.1155/2023/5827613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Chen J., Zhang J., Chen T., et al. Xiaojianzhong decoction attenuates gastric mucosal injury by activating the p62/Keap1/Nrf2 signaling pathway to inhibit ferroptosis. Biomed Pharmacother. 2022;155 doi: 10.1016/j.biopha.2022.113631. [DOI] [PubMed] [Google Scholar]
- 41.Wei J.C., Gao W.Y., Yan X.D., Wang Y., Jing S.S., Xiao P.G. Chemical constituents of plants from the genus Paris. Chem Biodivers. 2014;11(9):1277–1297. doi: 10.1002/cbdv.201300083. [DOI] [PubMed] [Google Scholar]
- 42.Zhou Y., Yang J., Chen C., et al. Polyphyllin Ⅲ-induced ferroptosis in MDA-MB-231 triple-negative breast cancer cells can be protected against by KLF4-mediated upregulation of xCT. Front Pharmacol. 2021;12 doi: 10.3389/fphar.2021.670224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Huang Q., Li J., Ma M., et al. High-throughput screening identification of a small-molecule compound that induces ferroptosis and attenuates the invasion and migration of hepatocellular carcinoma cells by targeting the STAT3/GPX4 axis. Int J Oncol. 2023;62(3):42. doi: 10.3892/ijo.2023.5490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Yang S., Xie Z., Pei T., et al. Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ1-42-induced Alzheimer’s disease mice and glutamate-injured HT22 cells. Chin Med. 2022;17(1):82. doi: 10.1186/s13020-022-00634-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Yang S., Wang L., Zeng Y., et al. Salidroside alleviates cognitive impairment by inhibiting ferroptosis via activation of the Nrf2/GPX4 axis in SAMP8 mice. Phytomedicine. 2023;114 doi: 10.1016/j.phymed.2023.154762. [DOI] [PubMed] [Google Scholar]
- 46.Shwter A.N., Abdullah N.A., Alshawsh M.A., et al. Chemoprevention of colonic aberrant crypt foci by Gynura procumbens in rats. J Ethnopharmacol. 2014;151(3):1194–1201. doi: 10.1016/j.jep.2013.12.044. [DOI] [PubMed] [Google Scholar]
- 47.Jiang X., Liu Y., Ma L., et al. Chemopreventive activity of sulforaphane. Drug Des Dev Ther. 2018;12:2905–2913. doi: 10.2147/DDDT.S100534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Wang X., Chen X., Zhou W., et al. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B. 2022;12(2):708–722. doi: 10.1016/j.apsb.2021.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Gao J., Yu H., Guo W., et al. The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells. Cancer Cell Int. 2018;18:102. doi: 10.1186/s12935-018-0595-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Cheng Y.H., Lin F.H., Wang C.Y., et al. Recovery of oxidative stress-induced damage in Cisd2-deficient cardiomyocytes by sustained release of ferulic acid from injectable hydrogel. Biomaterials. 2016;103:207–218. doi: 10.1016/j.biomaterials.2016.06.060. [DOI] [PubMed] [Google Scholar]
- 51.Nankar R., Prabhakar P.K., Doble M. Hybrid drug combination: combination of ferulic acid and metformin as anti-diabetic therapy. Phytomedicine. 2017;37:10–13. doi: 10.1016/j.phymed.2017.10.015. [DOI] [PubMed] [Google Scholar]
- 52.Liu X., Qi K., Gong Y., et al. Ferulic acid alleviates myocardial ischemia reperfusion injury via upregulating AMPKα2 expression-mediated ferroptosis depression. J Cardiovasc Pharmacol. 2021;79(4):489–500. doi: 10.1097/FJC.0000000000001199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Yang Y., Lei W., Qian L., et al. Activation of NR1H3 signaling pathways by psoralidin attenuates septic myocardial injury. Free Radic Biol Med. 2023;204:8–19. doi: 10.1016/j.freeradbiomed.2023.04.006. [DOI] [PubMed] [Google Scholar]
- 54.Yaseen A., Yang F., Zhang X., et al. Ferroptosis inhibitory constituents from the fruits of Cullen corylifolium. Nat Prod Res. 2021;35(23):5364–5368. doi: 10.1080/14786419.2020.1762188. [DOI] [PubMed] [Google Scholar]
- 55.Zhang W., Wang W., Shen C., Wang X., Pu Z., Yin Q. Network pharmacology for systematic understanding of schisandrin B reduces the epithelial cells injury of colitis through regulating pyroptosis by AMPK/Nrf2/NLRP3 inflammasome. Aging. 2021;13(19):23193–23209. doi: 10.18632/aging.203611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Cai N.N., Geng Q., Jiang Y., et al. Schisandrin A and B affect the proliferation and differentiation of neural stem cells. J Chem Neuroanat. 2022;119 doi: 10.1016/j.jchemneu.2021.102058. [DOI] [PubMed] [Google Scholar]
- 57.Pu H., Qian Q., Wang F., Gong M., Ge X. Schizandrin A induces the apoptosis and suppresses the proliferation, invasion and migration of gastric cancer cells by activating endoplasmic reticulum stress. Mol Med Rep. 2021;24(5):787. doi: 10.3892/mmr.2021.12427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Zong W., Gouda M., Cai E., et al. The antioxidant phytochemical schisandrin A promotes neural cell proliferation and differentiation after ischemic brain injury. Molecules. 2021;26(24):7466. doi: 10.3390/molecules26247466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Wang X., Li Q., Sui B., Xu M., Pu Z., Qiu T. Schisandrin A from Schisandra chinensis attenuates ferroptosis and NLRP3 inflammasome-mediated pyroptosis in diabetic nephropathy through mitochondrial damage by AdipoR1 ubiquitination. Oxid Med Cell Longev. 2022;2022 doi: 10.1155/2022/5411462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Chung J.H., Manganiello V., Dyck J.R.B. Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol. 2012;22(10):546–554. doi: 10.1016/j.tcb.2012.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Bagul P.K., Deepthi N., Sultana R., Banerjee S.K. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. J Nutr Biochem. 2015;26(11):1298–1307. doi: 10.1016/j.jnutbio.2015.06.006. [DOI] [PubMed] [Google Scholar]
- 62.Nunes S., Danesi F., Del Rio D., Silva P. Resveratrol and inflammatory bowel disease: the evidence so far. Nutr Res Rev. 2018;31(1):85–97. doi: 10.1017/S095442241700021X. [DOI] [PubMed] [Google Scholar]
- 63.Rauf A., Imran M., Butt M.S., Nadeem M., Peters D.G., Mubarak M.S. Resveratrol as an anti-cancer agent: a review. Crit Rev Food Sci Nutr. 2018;58(9):1428–1447. doi: 10.1080/10408398.2016.1263597. [DOI] [PubMed] [Google Scholar]
- 64.Li T., Tan Y., Ouyang S., He J., Liu L. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Gene. 2022;808 doi: 10.1016/j.gene.2021.145968. [DOI] [PubMed] [Google Scholar]
- 65.Tsai M.Y., Yang R.C., Wu H.T., Pang J.H.S., Huang S.T. Anti-angiogenic effect of tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells. Cancer Lett. 2011;310(2):198–206. doi: 10.1016/j.canlet.2011.06.031. [DOI] [PubMed] [Google Scholar]
- 66.Guo Z., Yan M., Chen L., et al. Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity. Exp Ther Med. 2018;16(4):3333–3344. doi: 10.3892/etm.2018.6614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Chen Z., Xu H. Anti-inflammatory and immunomodulatory mechanism of tanshinone IIA for atherosclerosis. Evid Based Compl Alternat Med. 2014;2014 doi: 10.1155/2014/267976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Zhou L.H., Hu Q., Sui H., et al. Tanshinone II-A inhibits angiogenesis through down regulation of COX-2 in human colorectal cancer. Asian Pac J Cancer Prev APJCP. 2012;13(9):4453–4458. doi: 10.7314/apjcp.2012.13.9.4453. [DOI] [PubMed] [Google Scholar]
- 69.Jiao J.W., Wen F. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells. Oncol Rep. 2011;25(3):781–788. doi: 10.3892/or.2010.1107. [DOI] [PubMed] [Google Scholar]
- 70.Ni H., Ruan G., Sun C., et al. Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis. Environ Toxicol. 2022;37(2):192–200. doi: 10.1002/tox.23388. [DOI] [PubMed] [Google Scholar]
- 71.Xie L., Tang H., Song J., Long J., Zhang L., Li X. Chrysophanol: a review of its pharmacology, toxicity and pharmacokinetics. J Pharm Pharmacol. 2019;71(10):1475–1487. doi: 10.1111/jphp.13143. [DOI] [PubMed] [Google Scholar]
- 72.Su S., Wu J., Gao Y., Luo Y., Yang D., Wang P. The pharmacological properties of chrysophanol, the recent advances. Biomed Pharmacother. 2020;125 doi: 10.1016/j.biopha.2020.110002. [DOI] [PubMed] [Google Scholar]
- 73.Ya-Hsuan L., Valeria C., Chun-Yen H., I-Shiang T., Po-Chun H., Chan-Yen K. Promotion of ferroptosis in oral cancer cell lines by chrysophanol. Curr Top Nutraceutical Res. 2020;18(3):273–276. [Google Scholar]
- 74.Birt D.F., Jeffery E. Flavonoids. Adv Nutr. 2013;4(5):576–577. doi: 10.3945/an.113.004465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Corcoran M.P., McKay D.L., Blumberg J.B. Flavonoid basics: chemistry, sources, mechanisms of action, and safety. J Nutr Gerontol Geriatr. 2012;31(3):176–189. doi: 10.1080/21551197.2012.698219. [DOI] [PubMed] [Google Scholar]
- 76.Serafini M., Peluso I., Raguzzini A. Flavonoids as anti-inflammatory agents. Proc Nutr Soc. 2010;69(3):273–278. doi: 10.1017/S002966511000162X. [DOI] [PubMed] [Google Scholar]
- 77.Pietta P.G. Flavonoids as antioxidants. J Nat Prod. 2000;63(7):1035–1042. doi: 10.1021/np9904509. [DOI] [PubMed] [Google Scholar]
- 78.Cushnie T.P., Lamb A.J. Antimicrobial activity of flavonoids. Int J Antimicrob Agents. 2005;26(5):343–356. doi: 10.1016/j.ijantimicag.2005.09.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Badshah S.L., Faisal S., Muhammad A., Poulson B.G., Emwas A.H., Jaremko M. Antiviral activities of flavonoids. Biomed Pharmacother. 2021;140 doi: 10.1016/j.biopha.2021.111596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Gonçalves C.F.L., de Freitas M.L., Ferreira A.C.F. Flavonoids, thyroid iodide uptake and thyroid cancer - a review. Int J Mol Sci. 2017;18(6):1247. doi: 10.3390/ijms18061247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Fan Z., Cai L., Wang S., Wang J., Chen B. Baicalin prevents myocardial ischemia/reperfusion injury through inhibiting ACSL4 mediated ferroptosis. Front Pharmacol. 2021;12 doi: 10.3389/fphar.2021.628988. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 82.Zhang Y., Huang Y., Deng X., Xu Y., Gao Z., Li H. Iron overload-induced rat liver injury: involvement of protein tyrosine nitration and the effect of baicalin. Eur J Pharmacol. 2012;680(1–3):95–101. doi: 10.1016/j.ejphar.2012.01.010. [DOI] [PubMed] [Google Scholar]
- 83.Guo C., Chen X., Xiong P. Baicalin suppresses iron accumulation after substantia nigra injury: relationship between iron concentration and transferrin expression. Neural Regen Res. 2014;9(6):630–636. doi: 10.4103/1673-5374.130108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Duan L., Zhang Y., Yang Y., et al. Baicalin inhibits ferroptosis in intracerebral hemorrhage. Front Pharmacol. 2021;12 doi: 10.3389/fphar.2021.629379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Sun C., Jin W., Shi H. Oligomeric proanthocyanidins protects A549 cells against H2O2-induced oxidative stress via the Nrf2-ARE pathway. Int J Mol Med. 2017;39(6):1548–1554. doi: 10.3892/ijmm.2017.2971. [DOI] [PubMed] [Google Scholar]
- 86.Jiang Y., Wang X., Yang W., Gui S. Procyanidin B2 suppresses lipopolysaccharides-induced inflammation and apoptosis in human type II alveolar epithelial cells and lung fibroblasts. J Interferon Cytokine Res. 2020;40(1):54–63. doi: 10.1089/jir.2019.0083. [DOI] [PubMed] [Google Scholar]
- 87.Lv Y.W., Du Y., Ma S.S., et al. Proanthocyanidins attenuates ferroptosis against influenza-induced acute lung injury in mice by reducing IFN-γ. Life Sci. 2023;314 doi: 10.1016/j.lfs.2022.121279. [DOI] [PubMed] [Google Scholar]
- 88.Du Y.W., Li X.K., Wang T.T., et al. Cyanidin-3-glucoside inhibits ferroptosis in renal tubular cells after ischemia/reperfusion injury via the AMPK pathway. Mol Med. 2023;29(1):42. doi: 10.1186/s10020-023-00642-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Patel R.V., Mistry B.M., Shinde S.K., Syed R., Singh V., Shin H.S. Therapeutic potential of quercetin as a cardiovascular agent. Eur J Med Chem. 2018;155:889–904. doi: 10.1016/j.ejmech.2018.06.053. [DOI] [PubMed] [Google Scholar]
- 90.Bardy G., Virsolvy A., Quignard J.F., et al. Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br J Pharmacol. 2013;169(5):1102–1113. doi: 10.1111/bph.12194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Yao Z., Gu Y., Zhang Q., et al. Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults. Eur J Nutr. 2019;58(2):819–830. doi: 10.1007/s00394-018-1713-2. [DOI] [PubMed] [Google Scholar]
- 92.Rauf A., Imran M., Khan I.A., et al. Anticancer potential of quercetin: a comprehensive review. Phytother Res. 2018;32(11):2109–2130. doi: 10.1002/ptr.6155. [DOI] [PubMed] [Google Scholar]
- 93.Cui S., Wu Q., Wang J., Li M., Qian J., Li S. Quercetin inhibits LPS-induced macrophage migration by suppressing the iNOS/FAK/paxillin pathway and modulating the cytoskeleton. Cell Adhes Migrat. 2019;13(1):1–12. doi: 10.1080/19336918.2018.1486142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Li D., Jiang C., Mei G., et al. Quercetin alleviates ferroptosis of pancreatic β cells in type 2 diabetes. Nutrients. 2020;12(10):2954. doi: 10.3390/nu12102954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Liu C.X. Discovery and development of artemisinin and related compounds. Chin Herb Med. 2017;9(2):101–114. [Google Scholar]
- 96.Peter S., Jama S., Alven S., Aderibigbe B.A. Artemisinin and derivatives-based hybrid compounds: promising therapeutics for the treatment of cancer and malaria. Molecules. 2021;26(24):7521. doi: 10.3390/molecules26247521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Zhao F., Vakhrusheva O., Markowitsch S.D., et al. Artesunate impairs growth in cisplatin-resistant bladder cancer cells by cell cycle arrest, apoptosis and autophagy induction. Cells. 2020;9(12):2643. doi: 10.3390/cells9122643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Raffetin A., Bruneel F., Roussel C., et al. Use of artesunate in non-malarial indications. Med Maladies Infect. 2018;48(4):238–249. doi: 10.1016/j.medmal.2018.01.004. [DOI] [PubMed] [Google Scholar]
- 99.Yao X., Zhao C.R., Yin H., Wang K., Gao J.J. Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells. Acta Pharmacol Sin. 2020;41(12):1609–1620. doi: 10.1038/s41401-020-0395-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Farmanpour-Kalalagh K., Beyraghdar Kashkooli A., Babaei A., Rezaei A., van der Krol A.R. Artemisinins in combating viral infections like SARS-CoV-2, inflammation and cancers and options to meet increased global demand. Front Plant Sci. 2022;13 doi: 10.3389/fpls.2022.780257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Li Z.J., Dai H.Q., Huang X.W., et al. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacol Sin. 2021;42(2):301–310. doi: 10.1038/s41401-020-0478-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Jiang F., Zhou J.Y., Zhang D., Liu M.H., Chen Y.G. Artesunate induces apoptosis and autophagy in HCT116 colon cancer cells, and autophagy inhibition enhances the artesunate-induced apoptosis. Int J Mol Med. 2018;42(3):1295–1304. doi: 10.3892/ijmm.2018.3712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Lee Y.S., Lee D.H., Jeong S.Y., et al. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5. J Cell Biochem. 2019;120(1):928–939. doi: 10.1002/jcb.27456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Greenshields A.L., Shepherd T.G., Hoskin D.W. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate. Mol Carcinog. 2017;56(1):75–93. doi: 10.1002/mc.22474. [DOI] [PubMed] [Google Scholar]
- 105.Koike T., Takenaka M., Suzuki N., et al. Intracellular ferritin heavy chain plays the key role in artesunate-induced ferroptosis in ovarian serous carcinoma cells. J Clin Biochem Nutr. 2022;71(1):34–40. doi: 10.3164/jcbn.21-82. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Wang N., Zeng G.Z., Yin J.L., Bian Z.X. Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt’s lymphoma. Biochem Biophys Res Commun. 2019;519(3):533–539. doi: 10.1016/j.bbrc.2019.09.023. [DOI] [PubMed] [Google Scholar]
- 107.Chen Y., Mi Y., Zhang X., et al. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells. J Exp Clin Cancer Res. 2019;38(1):402. doi: 10.1186/s13046-019-1413-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Ooko E., Saeed M.E.M., Kadioglu O., et al. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine. 2015;22(11):1045–1054. doi: 10.1016/j.phymed.2015.08.002. [DOI] [PubMed] [Google Scholar]
- 109.Du J., Wang T., Li Y., et al. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radic Biol Med. 2019;131:356–369. doi: 10.1016/j.freeradbiomed.2018.12.011. [DOI] [PubMed] [Google Scholar]
- 110.Thoennissen N.H., Iwanski G.B., Doan N.B., et al. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res. 2009;69(14):5876–5884. doi: 10.1158/0008-5472.CAN-09-0536. [DOI] [PubMed] [Google Scholar]
- 111.Chen J.C., Chiu M.H., Nie R.L., Cordell G.A., Qiu S.X. Cucurbitacins and cucurbitane glycosides: structures and biological activities. Nat Prod Rep. 2005;22(3):386–399. doi: 10.1039/b418841c. [DOI] [PubMed] [Google Scholar]
- 112.Dakeng S., Duangmano S., Jiratchariyakul W., U-Pratya Y., Bögler O., Patmasiriwat P. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus. J Cell Biochem. 2012;113(1):49–60. doi: 10.1002/jcb.23326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Alafnan A., Khalifa N.E., Hussain T., Osman M.E. Cucurbitacin-B instigates intrinsic apoptosis and modulates Notch signaling in androgen-dependent prostate cancer LNCaP cells. Front Pharmacol. 2023;14 doi: 10.3389/fphar.2023.1206981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Huang S., Cao B., Zhang J., et al. Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential. Cell Death Dis. 2021;12(3):237. doi: 10.1038/s41419-021-03516-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Huang C.C., Lo C.P., Chiu C.Y., Shyur L.F. Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in mice. Br J Pharmacol. 2010;159(4):856–871. doi: 10.1111/j.1476-5381.2009.00581.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Lee W.L., Wen T.N., Shiau J.Y., Shyur L.F. Differential proteomic profiling identifies novel molecular targets of paclitaxel and phytoagent deoxyelephantopin against mammary adenocarcinoma cells. J Proteome Res. 2010;9(1):237–253. doi: 10.1021/pr900543e. [DOI] [PubMed] [Google Scholar]
- 117.Chang M.T., Tsai L.C., Nakagawa-Goto K., Lee K.H., Shyur L.F. Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sensitive and resistant melanoma via GPX4 inhibition and metabolic reprogramming. Pharmacol Res. 2022;178 doi: 10.1016/j.phrs.2022.106148. [DOI] [PubMed] [Google Scholar]
- 118.Pollier J., Goossens A. Oleanolic acid. Phytochemistry. 2012;77:10–15. doi: 10.1016/j.phytochem.2011.12.022. [DOI] [PubMed] [Google Scholar]
- 119.Zhang W., Feng J., Cheng B., Lu Q., Chen X. Oleanolic acid protects against oxidative stress-induced human umbilical vein endothelial cell injury by activating AKT/eNOS signaling. Mol Med Rep. 2018;18(4):3641–3648. doi: 10.3892/mmr.2018.9354. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Kashyap D., Sharma A., Tuli H.S., Punia S., Sharma A.K. Ursolic acid and oleanolic acid: pentacyclic terpenoids with promising anti-inflammatory activities. Recent Pat Inflamm Allergy Drug Discov. 2016;10(1):21–33. doi: 10.2174/1872213x10666160711143904. [DOI] [PubMed] [Google Scholar]
- 121.Sánchez-Quesada C., López-Biedma A., Gaforio J.J. Oleanolic acid, a compound present in grapes and olives, protects against genotoxicity in human mammary epithelial cells. Molecules. 2015;20(8):13670–13688. doi: 10.3390/molecules200813670. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Jiang X., Shi M., Sui M., et al. Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway. Biochem Biophys Res Commun. 2021;545:81–88. doi: 10.1016/j.bbrc.2021.01.028. [DOI] [PubMed] [Google Scholar]
- 123.Shen D., Wang Y., Niu H., Liu C. Gambogenic acid exerts anticancer effects in cisplatin-resistant non-small cell lung cancer cells. Mol Med Rep. 2020;21(3):1267–1275. doi: 10.3892/mmr.2020.10909. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Yan F., Wang M., Chen H., et al. Gambogenic acid-mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells. Eur J Pharmacol. 2011;652(1–3):23–32. doi: 10.1016/j.ejphar.2010.11.018. [DOI] [PubMed] [Google Scholar]
- 125.Wang M., Li S., Wang Y., Cheng H., Su J., Li Q. Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition. Toxicol Appl Pharmacol. 2020;401 doi: 10.1016/j.taap.2020.115110. [DOI] [PubMed] [Google Scholar]
- 126.Li B., Yang Y., Chen L., Chen S., Zhang J., Tang W. 18α-Glycyrrhetinic acid monoglucuronide as an anti-inflammatory agent through suppression of the NF-κB and MAPK signaling pathway. MedChemComm. 2017;8(7):1498–1504. doi: 10.1039/c7md00210f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Shafik N.M., El-Esawy R.O., Mohamed D.A., Deghidy E.A., El-Deeb O.S. Regenerative effects of glycyrrhizin and/or platelet rich plasma on type-II collagen induced arthritis: targeting autophay machinery markers, inflammation and oxidative stress. Arch Biochem Biophys. 2019;675 doi: 10.1016/j.abb.2019.108095. [DOI] [PubMed] [Google Scholar]
- 128.Pompei R., Flore O., Marccialis M.A., Pani A., Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature. 1979;281(5733):689–690. doi: 10.1038/281689a0. [DOI] [PubMed] [Google Scholar]
- 129.Cai Y., Zhao B., Liang Q., Zhang Y., Cai J., Li G. The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase IIα and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells. Eur J Pharmacol. 2017;809:87–97. doi: 10.1016/j.ejphar.2017.05.026. [DOI] [PubMed] [Google Scholar]
- 130.Wen Y., Chen H., Zhang L., et al. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells. Free Radic Biol Med. 2021;173:41–51. doi: 10.1016/j.freeradbiomed.2021.07.019. [DOI] [PubMed] [Google Scholar]
- 131.Guo F., Shi L.R., Zhang X.Y., et al. Inhibitory effect of solasonine on the proliferation of human bladder cancer 5637 cells and its mechanism. Biotechnology. 2020;30:489–494. [Google Scholar]
- 132.Yan Z.P., Wang X.S., Xu T.T., et al. Apoptosis of cholangiocarcinoma QBC939 cells induced by solasonine and its mechanism. Nat Prod Res Dev. 2017;29:559–562. [Google Scholar]
- 133.Shi F., Wu L., Wang Y., et al. Effects of solasonine on the invasion of lung cancer cells and the expression of MMPs/TIMPs. Cancer Pharmacol. 2018;8:337–341. [Google Scholar]
- 134.Liang X., Hu C., Han M., et al. Solasonine inhibits pancreatic cancer progression with involvement of ferroptosis induction. Front Oncol. 2022;12 doi: 10.3389/fonc.2022.834729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Ju J., Li J., Lin Q., Xu H. Efficacy and safety of berberine for dyslipidaemias: a systematic review and meta-analysis of randomized clinical trials. Phytomedicine. 2018;50:25–34. doi: 10.1016/j.phymed.2018.09.212. [DOI] [PubMed] [Google Scholar]
- 136.Simões Pires E.N., Frozza R.L., Hoppe J.B., Menezes B.D., Salbego C.G. Berberine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved. Brain Res. 2014;1557:26–33. doi: 10.1016/j.brainres.2014.02.021. [DOI] [PubMed] [Google Scholar]
- 137.Chen W., Wei S., Yu Y., et al. Pretreatment of rats with increased bioavailable berberine attenuates cerebral ischemia-reperfusion injury via down regulation of adenosine-5’monophosphate kinase activity. Eur J Pharmacol. 2016;779:80–90. doi: 10.1016/j.ejphar.2016.03.015. [DOI] [PubMed] [Google Scholar]
- 138.Wang X., Zhang J., Wang S., et al. Berberine modulates gut microbiota to attenuate cerebral ferroptosis induced by ischemia-reperfusion in mice. Eur J Pharmacol. 2023;953 doi: 10.1016/j.ejphar.2023.175782. [DOI] [PubMed] [Google Scholar]
- 139.Li Y.Y., Lin Y.K., Liu X.H., et al. Leonurine: from gynecologic medicine to pleiotropic agent. Chin J Integr Med. 2020;26(2):152–160. doi: 10.1007/s11655-019-3453-0. [DOI] [PubMed] [Google Scholar]
- 140.Liu X.H., Chen P.F., Pan L.L., Silva R.D., Zhu Y.Z. 4-Guanidino-n-butyl syringate (Leonurine, SCM 198) protects H9c2 rat ventricular cells from hypoxia-induced apoptosis. J Cardiovasc Pharmacol. 2009;54(5):437–444. doi: 10.1097/FJC.0b013e3181bae160. [DOI] [PubMed] [Google Scholar]
- 141.Hu J., Gu W., Ma N., Fan X., Ci X. Leonurine alleviates ferroptosis in cisplatin-induced acute kidney injury by activating the Nrf2 signalling pathway. Br J Pharmacol. 2022;179(15):3991–4009. doi: 10.1111/bph.15834. [DOI] [PubMed] [Google Scholar]
- 142.Salama S.A., Abdel-Bakky M.S., Mohamed A.A. Upregulation of Nrf2 signaling and suppression of ferroptosis and NF-κB pathway by leonurine attenuate iron overload-induced hepatotoxicity. Chem Biol Interact. 2022;356 doi: 10.1016/j.cbi.2022.109875. [DOI] [PubMed] [Google Scholar]
- 143.Liu G.T. Bicyclol: a novel drug for treating chronic viral hepatitis B and C. Med Chem. 2009;5(1):29–43. doi: 10.2174/157340609787049316. [DOI] [PubMed] [Google Scholar]
- 144.Zhao T., Mao L., Yu Z., et al. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine. Int Immunopharm. 2021;91 doi: 10.1016/j.intimp.2020.107308. [DOI] [PubMed] [Google Scholar]
- 145.Zhao T., Yu Z., Zhou L., et al. Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice. Cell Death Dis. 2022;8(1):380. doi: 10.1038/s41420-022-01173-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Zheng Y., Ren W., Zhang L., Zhang Y., Liu D., Liu Y. A review of the pharmacological action of Astragalus polysaccharide. Front Pharmacol. 2020;11:349. doi: 10.3389/fphar.2020.00349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Li W., Hu X., Wang S., et al. Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation. Int J Biol Macromol. 2020;145:985–997. doi: 10.1016/j.ijbiomac.2019.09.189. [DOI] [PubMed] [Google Scholar]
- 148.Zhang Y.M., Zhang L.Y., Zhou H., et al. Astragalus polysaccharide inhibits radiation-induced bystander effects by regulating apoptosis in bone mesenchymal stem cells (BMSCs) Cell Cycle. 2020;19(22):3195–3207. doi: 10.1080/15384101.2020.1838793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Bamodu O.A., Kuo K.T., Wang C.H., et al. Astragalus polysaccharides (PG2) enhances the M1 polarization of macrophages, functional maturation of dendritic cells, and T cell-mediated anticancer immune responses in patients with lung cancer. Nutrients. 2019;11(10):2264. doi: 10.3390/nu11102264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Liu J., Liu J., Liu L., Zhang G., Zhou A., Peng X. The gut microbiota alteration and the key bacteria in Astragalus polysaccharides (APS)-improved osteoporosis. Food Res Int. 2020;138(Pt B) doi: 10.1016/j.foodres.2020.109811. [DOI] [PubMed] [Google Scholar]
- 151.Chen Y., Wang J., Li J., et al. Astragalus polysaccharide prevents ferroptosis in a murine model of experimental colitis and human Caco-2cells via inhibiting NRF2/HO-1 pathway. Eur J Pharmacol. 2021;911 doi: 10.1016/j.ejphar.2021.174518. [DOI] [PubMed] [Google Scholar]
- 152.Zhai B., Zhang N., Han X., et al. Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: a review. Biomed Pharmacother. 2019;114 doi: 10.1016/j.biopha.2019.108812. [DOI] [PubMed] [Google Scholar]
- 153.Tan T., Li J., Luo R., et al. Recent advances in understanding the mechanisms of elemene in reversing drug resistance in tumor cells: a review. Molecules. 2021;26(19):5792. doi: 10.3390/molecules26195792. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154.Jiang X., Hidru T.H., Zhang Z., Bai Y., Kong L., Li X. Evidence of elemene injection combined radiotherapy in lung cancer treatment among patients with brain metastases: a systematic review and meta-analysis. Medicine. 2017;96(21) doi: 10.1097/MD.0000000000006963. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 155.Chen P., Li X., Zhang R., et al. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics. 2020;10(11):5107–5119. doi: 10.7150/thno.44705. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.Mishima E., Ito J., Wu Z., et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature. 2022;608(7924):778–783. doi: 10.1038/s41586-022-05022-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007;70(3):461–477. doi: 10.1021/np068054v. [DOI] [PubMed] [Google Scholar]
- 158.Wang L., Liu C., Wang L., Tang B. Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis. Eur J Pharmacol. 2023;944 doi: 10.1016/j.ejphar.2023.175516. [DOI] [PubMed] [Google Scholar]
- 159.Zhou C., Yu T., Zhu R., et al. Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation. Int J Biol Sci. 2023;19(5):1471–1489. doi: 10.7150/ijbs.77979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160.Wang Y.L., Hong T., Zeng H.R., Yuan Y. Mechanism of ophiopogonin B inhibiting the proliferation of non-small cell lung cancer A549 cells by promoting cell ferroptosis. Chin J Hosp Pharm. 2022;19:1983–1988. [Google Scholar]
- 161.Gao W., Wang J.Y. Effects of saikosaponin A on the sensibility of cisplatin in A549 cells based on Nrf2/HO-1 pathway. Chin J Inform TCM. 2023;1:121–127. [Google Scholar]
- 162.Han S.F., Guan L.L., Li S.P., Wang M.J., Zhou K.X., Xi S.M. The mechanism of α-Hederin induced ferroptosis in hepatoma Bel-7402 cells. Moder Oncol. 2022;19:3467–3472. [Google Scholar]
- 163.Wang S.J., Liu W., Wang J., Bai X. Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4. Life Sci. 2020;259 doi: 10.1016/j.lfs.2020.118356. [DOI] [PubMed] [Google Scholar]
- 164.Lin Y., Yang C.Q., Lian W.Y., et al. Ophiopogonin D interferes with ferroptosis to reduce the damage of cardiomyocytes induced by ophiopogoninD'. Acta Pharm Sin. 2021;8:2241–2247. [Google Scholar]
- 165.Lian L.B., Chen B., Duan B. Influence of paeoniflorin on ferroptosis in rats with gestational diabetes mellitus by regulating Akt/Nrf2/GPX4 pathway. Chin J Eugen Genet. 2023;31:22–26. [Google Scholar]
- 166.Chen X., Liu X.X., Wang W.J., Wang M., Chen H. Ferroptosis in melanoma cells B16F10 induced by polyphyllin Ⅱ. Centr South Pharm. 2023;21:279–284. [Google Scholar]
- 167.He D., Li L.P., Tan X.N., Gao W.H., Tian X.F., Zeng P.H. Mechanism of esculetin promoting ferroptosis of mouse breast cancer 4T1 cells based on p53/SLC7A11/GPX4 axis. Chin J Pathophysiol. 2024;40:282–290. [Google Scholar]
- 168.Zhao L.N., Ge G.L., Han X. Effects of osthole on lung injury improvement in rats with mycoplasma pneumoniae pneumonia via Nrf2-Gpx4 ferroptosis pathway. Chin Tradit Pat Med. 2023;45:48–54. [Google Scholar]
- 169.Tan G.Y., Cai P.H., Cao L., Wang D.F., Jing J. Effect of cryptotanshinone on ferroptosis-related gene expression in lung cancer cells. Chin Pharmacol Bull. 2019;35(12):1654–1659. [Google Scholar]
- 170.Wu C.Y., Yang Y.H., Lin Y.S., et al. Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells. Biomed Pharmacother. 2021;139 doi: 10.1016/j.biopha.2021.111585. [DOI] [PubMed] [Google Scholar]
- 171.Wu C., Duan F., Yang R., Dai Y., Chen X., Li S. 15, 16-Dihydrotanshinone I protects against ischemic stroke by inhibiting ferroptosis via the activation of nuclear factor erythroid 2-related factor 2. Phytomedicine. 2023;114 doi: 10.1016/j.phymed.2023.154790. [DOI] [PubMed] [Google Scholar]
- 172.Qian X., Zhu L., Xu M., et al. Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation. Chem Biol Interact. 2023;382 doi: 10.1016/j.cbi.2023.110588. [DOI] [PubMed] [Google Scholar]
- 173.Li Z.H., Zhou Z.H., Wang R., Li Y.Y., Li H. Effect and molecular mechanism of acetylshikonin induced ferroptosis in acute myelogenous leukemia HL-60 cells. Moder Oncol. 2023;31(14):2581–2588. [Google Scholar]
- 174.Gao J., Ma C., Xia D., et al. Icariside II preconditioning evokes robust neuroprotection against ischaemic stroke, by targeting Nrf2 and the OXPHOS/NF-κB/ferroptosis pathway. Br J Pharmacol. 2023;180(3):308–329. doi: 10.1111/bph.15961. [DOI] [PubMed] [Google Scholar]
- 175.Guo L., Shi L. Vitexin improves cerebral ischemia-reperfusion injury by attenuating oxidative injury and ferroptosis via Keap1/Nrf2/HO-1signaling. Neurochem Res. 2023;48(3):980–995. doi: 10.1007/s11064-022-03829-0. [DOI] [PubMed] [Google Scholar]
- 176.Shang J.F., Jiao J.K., Li Q.N., et al. Chrysin alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis in rats. Zhongguo Zhongyao Zazhi. 2023;48(6):1597–1605. doi: 10.19540/j.cnki.cjcmm.20221201.705. [DOI] [PubMed] [Google Scholar]
- 177.Xie J., Zhang T., Li P., Wang D., Liu T., Xu S. Dihydromyricetin attenuates cerebral ischemia reperfusion injury by inhibiting SPHK1/mTOR signaling and targeting ferroptosis. Drug Des Dev Ther. 2022;16:3071–3085. doi: 10.2147/DDDT.S378786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Guan X. Protective effect and mechanism of galangin on hippocampal neurons of cerebral ischemia-reperfusion injury in gerbils. Liaoning Univ Trad Chin Med. 2022 [Google Scholar]
- 179.Li M. Ji Lin University; 2022. Mechanism Study of Baicalein on Cerebral Ischemia-Reperfusion Injury Regarding Ferroptosis Inhibition. [Google Scholar]
- 180.Li S., Li L., Min S., et al. Soybean isoflavones alleviate cerebral ischemia/reperfusion injury in rats by inhibiting ferroptosis and inflammatory cascade reaction. Nan Fang Yi Ke Da Xue Xue Bao. 2023;43(2):323–330. doi: 10.12122/j.issn.1673-4254.2023.02.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 181.Liu H., Zhao Z., Yan M., Zhang Q., Jiang T., Xue J. Calycosin decreases cerebral ischemia/reperfusion injury by suppressing ACSL4-dependent ferroptosis. Arch Biochem Biophys. 2023;734 doi: 10.1016/j.abb.2022.109488. [DOI] [PubMed] [Google Scholar]
- 182.Tang X., Ding H., Liang M., et al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac Cancer. 2021;12(8):1219–1230. doi: 10.1111/1759-7714.13904. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183.Lou J.S., Zhao L.P., Huang Z.H., et al. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer. Phytomedicine. 2021;80 doi: 10.1016/j.phymed.2020.153370. [DOI] [PubMed] [Google Scholar]
- 184.Gao M.L., Lai K., Deng Y., et al. Eriocitrin inhibits proliferation and migration of lung adenocarcinoma cells by regulating epithelial mesenchymal transition. J Hainan Med Univ. 2023;29:190–197. [Google Scholar]
- 185.Feng S., Li Y., Huang H., et al. Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6/Nrf2/GPX4 signaling pathway. Eur J Pharmacol. 2023;954 doi: 10.1016/j.ejphar.2023.175853. [DOI] [PubMed] [Google Scholar]
- 186.Ma C.J., Ma X.J., Bao H.Y., Han M., Zhai H.L., Lu P.C. Luteolin regulates Nrf2-Gpx4-mediated iron death pathway to inhibit AngⅡ-induced cardiomyocyte hypertrophy. J Chin Med Mater. 2022;45:2731–2736. [Google Scholar]
- 187.Fu C., Wu Y., Liu S., et al. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia. J Ethnopharmacol. 2022;289 doi: 10.1016/j.jep.2022.115021. [DOI] [PubMed] [Google Scholar]
- 188.Hu Q., Zuo T., Deng L., et al. β-caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats. Phytomedicine. 2022;102 doi: 10.1016/j.phymed.2022.154112. [DOI] [PubMed] [Google Scholar]
- 189.Zhang R., Pan T., Xiang Y., et al. Curcumenol triggered ferroptosis in lung cancer cells via lncRNA H19/miR-19b-3p/FTH1 axis. Bioact Mater. 2021;13:23–36. doi: 10.1016/j.bioactmat.2021.11.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 190.Fu Y.W., Wu Z.K., Li P.X., et al. Effects and mechanism of ß-carotene on LPS-induced acute kidney injury of mice. Chin Pharmaceut J. 2023;58(4):331–337. [Google Scholar]
- 191.Wei Y.L., Li Y., Huang S., et al. Inhibitory effect of β-elemenic acid on human esophageal cancer cell Eca-109. J Hubei Univ Sci Technol. 2023;37:15–20. [Google Scholar]
- 192.Luo P., Liu D., Zhang Q., et al. Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1. Acta Pharm Sin B. 2022;12(5):2300–2314. doi: 10.1016/j.apsb.2021.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 193.Qiu S., Yang L., Tan R.Z., Liu J. Effects of obacunone on renal interstitial fibrosis and ferroptosis in unilateral ureteral obstruction model mice. China Pharm. 2023;34:554–559. [Google Scholar]
- 194.Lu J.H., Liu A.J. Crocetin inhibits high glucose-induced ferroptosis in human glomerular mesangial cells through regulating Nrf2/HO-1 pathway. Tradit Chin Drug Res Clin Pharmacol. 2023;34:8–15. [Google Scholar]
- 195.Zhang Y.T., Xie X.J., Wang C.Y., Zhang M.L. Ganoderic acid A reduces sevoflurane-induced ferroptosis of HT22 cells through activating the Nrf2/GPX4 signaling pathway. J Hunan Univ Chin Med. 2022;42:1064–1069. [Google Scholar]
- 196.Shao M., Jiang Q., Shen C., Liu Z., Qiu L. Sinapine induced ferroptosis in non-small cell lung cancer cells by upregulating transferrin/transferrin receptor and downregulating SLC7A11. Gene. 2022;827 doi: 10.1016/j.gene.2022.146460. [DOI] [PubMed] [Google Scholar]
- 197.Xu R., Wu J., Luo Y., et al. Sanguinarine represses the growth and metastasis of non-small cell lung cancer by facilitating ferroptosis. Curr Pharmaceut Des. 2022;28(9):760–768. doi: 10.2174/1381612828666220217124542. [DOI] [PubMed] [Google Scholar]
- 198.Liu H., He S., Wang J., et al. Tetrandrine ameliorates traumatic brain injury by regulating autophagy to reduce ferroptosis. Neurochem Res. 2022;47(6):1574–1587. doi: 10.1007/s11064-022-03553-9. [DOI] [PubMed] [Google Scholar]
- 199.Li X.Y., Chu Y.J., Dou M.M., Ma R., Li S.L., Zhu L. Improvement effect and mechanism of matrine on experimental autoimmune encephalomyelitis mice. China Pharm. 2023;34:1177–1181. [Google Scholar]
- 200.Zhang W., Jiang B., Liu Y., Xu L., Wan M. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4. Free Radic Biol Med. 2022;180:75–84. doi: 10.1016/j.freeradbiomed.2022.01.009. [DOI] [PubMed] [Google Scholar]
- 201.Huang J., Deng C., Guo T., et al. Cinobufotalin induces ferroptosis to suppress lung cancer cell growth by lncRNA LINC00597/hsa-miR-367-3p/TFRC pathway via resibufogenin. Anti Cancer Agents Med Chem. 2023;23(6):717–725. doi: 10.2174/1871520622666221010092922. [DOI] [PubMed] [Google Scholar]
- 202.Zhang Y.G., Ye P., Zhu H., et al. Neutral polysaccharide from Gastrodia elata alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis-mediated neuroinflammation via the NRF2/HO-1 signaling pathway. CNS Neurosci Ther. 2024;30(3) doi: 10.1111/cns.14456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 203.Gao W., Zeng H.R., Le J.M. Brusatol suppresses proliferation of human gastric cancer HGC-27 cells through inducing ferroptosis via Nrf2/HO-1 pathway. Chin J Exp Tradit Med Formulae. 2023;29:81–87. [Google Scholar]
- 204.Chen P., Wu Q., Feng J., et al. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis. Signal Transduct Targeted Ther. 2020;5(1):51. doi: 10.1038/s41392-020-0149-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 205.Zhang Y.X., Huang M., Cao G.D., et al. Mechanism of andrographolide alleviates lipopolysaccharide-induced ferroptosis in renal tubular epithelial cells. Chin J Infect Control. 2024;23:568–574. [Google Scholar]




